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Now that summer is here, hopefully, we will 
all have some time to enjoy the warm 
weather and be able to get away from our 
daily work routine for some relaxation. 
As many of you know, the members of Allen 
Neurosurgical Association (ANA) have 
announced that after July 1, 1999, they will 
no longer provide neurosurgical coverage of 
the trauma service at Lehigh Valley Hospital 
(LVH). This announcement appeared in the 
Morning Call with an accompanying article 
during the first week of June. The group 
announced their intention to the LVH 
administration in a letter dated March 8, 
1999. Since that time, numerous 
discussions have occurred between the 
hospital administration, the Chairperson of 
the Department of Surgery, the Chief of the 
Trauma Service, and members of TROIKA 
with representatives of ANA to address their 
concerns related to trauma coverage. 
Unfortunately, these discussions have not 
met with success and it appears that the 
remaining members of the group will 
proceed with their intention to withdraw from 
trauma coverage. We have been assured 
that adequate coverage of neurosurgical 
trauma has been secured and that the 
trauma program will continue to function 
without interruption as our hospital, its 
medical staff, our patients and our 
community have come to expect. 
At the June General Medical Staff meeting, 
there was a free ranging discussion of this 
issue. This discussion, which was at times 
contentious,_ provided an opportunity for the 
medical staff members in attendance to 
(Continued on Page 2) 
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understand the issues involved and a chronological history of 
the efforts to solve.this apparent impasse. Members ofthe 
staff need to know that the Medical Staff Bylaws and the rules 
and regulations of the Division of Neurosurgery require active 
members of the staff to provide coverage for the Emergency 
Room and the Trauma Program, unless excused by the 
chairperson of the department in which the medical staff 
member has his/her appointment. The implication of these 
bylaws and rules and regulations is that if the members of ANA 
do not provide coverage for the trauma program, the Medical 
Executive Committee and the Board of Trustees of the hospital 
will be forced to terminate the clinical privileges of the 
members of ANA, thus, terminating their membership on the 
LVH Medical Staff. This will truly be a "lose-lose" scenario for 
both the institution and the members of ANA, who we have 
valued as our professional colleagues for many years. This 
will be a tragedy. 
What lessons can we all learn from this unfortunate set of 
circumstances, so that we can prevent the reoccurrence of a 
similar episode in the future? 
Since the beginning of my term as your President, I've been 
trying to encourage a collaborative approach between the 
Medical Staff and the hospital administration. Issues that 
develop in the future need to be addressed by both sides 
coming to the table to discuss them in an open and 
collaborative way. The goal of any discussions should be to 
find a mutually acceptable solution to controversies, which 
hopefully, can satisfy the needs of both parties. We need to 
begin to build relationships that are seen to be positive by their 
commitment at the outset to solving problems in a mutually 
satisfactory manner. Neither side should initiate discussions 
with threats. Both sides need to understand the implications of 
any controversy on the other. Sitting down with the "will" to 
solve an issue, so that the result can be positive for both sides, 
should be the goal. Our issues with the hospital administration 
should not be approached as a labor negotiation to be solved 
by threats of a "strike" or "taking our patients somewhere else." 
The goals of the Medical Staff and the hospital should be to 
build the best relationship, so that our patients and the 
community can receive the highest quality medical care. We 
need to remember that our primary responsibility as 
physicians should be to our patients. Hopefully, if we keep 
this in mind, we will be able to craft positive solutions to issues 
that develop between this Medical Staff and our hospital 
administration. 
As physicians, many of us trained in the era when hospitals 
were reimbursed by what they did for patients and the length of 
time patients were admitted. The longer the patient stayed in 
the hospital and the more we did, the better the hospital did 
financially. I'm sure that many of you remember the culture, 
which developed during our medical school and residency 
training, where we learned how to deal with "all" of the patier+'c: 
problems and to order any test or procedure which might e\( 
remotely be useful to the patient's care. We felt we were doing 
a wonderful job for our patients by addressing all of their 
problems, collecting "baseline" data for future records, and 
doing tests and procedures for "academic interest." As they 
say, "that was then and this is now.· Obviously, we all know 
that reimbursement methods have changed. We now have 
"prospective payment," "case based reimbursement,• DRG's, 
managed care, capitation, PPO's, HMO's, PSO's, "risk 
sharing,· etc. These changes in reimbursement have greatly 
changed the way we practice. However, most of us still live in 
the same culture in which we were trained. We haven't 
learned how to practice in new and efficient ways, which will 
allow us to continue to provide the highest quality patient care, 
while still maintaining the financial solubility for our practices 
and our hospital, which is necessary if we are to develop new 
programs and techniques to care for our patients and our 
community. We need to learn how to live in a "new culture" 
different from the one in which we were trained - a culture 
where we recognize that our nation's health care resources are 
finite and limited. We need to learn to be the stewards of 
these resources while still being the advocates for our 
individual patients. Every day we need to think about ways in 
which we can help to "take work out of the system." We need 
to ask ourselves not "why didn't I order .·but "why d~ 
order_." As I've asked you before, every time you order e:a 
test or procedure, ask yourself "how is the result of this test or 
procedure going to change the way I manage this patient?" 
"Could the things I'm doing for my patient in the hospital today 
be done in a more comfortable setting and at less expense in 
some other setting?" Although there is still much "art" to the 
practice of medicine, we should try, as much as possible, to 
base our clinical decisions on evidence where it exists, and 
not on anecdote and personal experience. 
e;;Mail , ,, . .. 
·:1{5 ·aiVJays; I'd like to·encourag'ealhmembers Qf.th~; ·· · 
· Medic,aiStaff to read their~ailregulaiiy or;to designate ··.·. 
•a staffmemberJo be yourappointed ·~urtogate~ wlio ean ·· 
:read and piintout·your e-maiFmessages'foryou on :a daily ·· 
:basis: · · · 
Sit Answer and Touch! 
Remember, when you are making hospital rounds, sit at your 
patienfs bedside, ask for their questions, answer their 
questions, and make physical contact with the patient. 
(Continued on Page 3) 
( 
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Just last week, I had a conversation with a patient's daughter 
who told me how very much it meant to her mother when the 
doctor would come in her room and sit down at her bedside 
and hold her mother's hand. This little gesture means a lot to 
both the patient and their family. 
Members of the Medical Staff will soon be receiving a 
"Physician Satisfaction Survey." Even though it is long and 
may be somewhat time intensive to complete, I encourage you 
to complete and return this survey so that the hospital 
administration can make the changes which will improve the 
efficiency of our care, and help to improve physician 
satisfaction with the hospital and its staff. 
Also, some of you will be receiving a survey which has been 
developed by Linda Lapos, chair of the Medical Records 
Committee, to help us assess physician satisfaction with the 
Lehigh Valley Hospital patient medical record. Your input into 
this process will be greatly appreciated. Hopefully, based 
upon the results of this survey, we will be able to make the 
patient medical record more useful and easier for each of us to 
use as we make our daily hospital rounds. 
As many of you know, Dr. Joseph Gastinger is ill with ALS. He 
is presently at home and requires a great deal of care from his 
incredibly supportive wife and from others who have 
volunteered their time to assist him. The Medical Staff has 
established a fund to help Joe and his family meet the financial 
burdens of his care. "The Joseph Gastinger Fund" will be 
funded solely by contributions from members of the Medical 
Staff and the hospital family who wish to help Joe and his 
family during the period of his long illness. Individuals wishing 
to make a contribution to the fund should make their check 
payable to "The Joseph Gastinger Fund" and forward it to Beth 
Martin, Medical Staff Services Office, Lehigh Valley Hospital, 
Cedar Crest & 1-78, P.O. Box 689, Allentown, PA 18105-1556. 
Lastly, let's all work in a collaborative way for the betterment of 
our patients. After all, are they not the primary reason that 
leads us all to choose a career in medicine? Such an 
approach will serve us best in the end. 
Have a great month! 
&aJl 
David M. Caccese, MD 
Medical Staff President 
Legislative Update 
The Civil Justice Coalition, which includes the Pennsylvania 
Medical Society, urges you to contact your Senator to 
encourage their support for Senate Bill 5 introduced by 
Senator Robert Thompson. The reform element in Senate Bill 
~ ~at is o.f p~m~.ry interest to physicians is the repeal of 
JOJntness 1n hab1hty. The principle of full comparative 
responsibility in Senate Bill 5 protects physicians from being 
seen as the "deep pocket• in liability cases who are held 
responsible for someone else's error or mistake. There are 
other reform provisions that require attorneys who file frivolous 
suits be penalized and that juries be informed about additional 
compensation a plaintiff may receive. 
Obviously, this is a very important issue to physicians. Please 
take a few minutes from your schedule to call or write your 
Senator regarding Senate Bill 5. If you need the name, 
addre~ or phone number of your Senator, please contact Mr. 
Lou E1ster at the Lehigh County Medical Society at (61 O) 437-
2288 .or the Pennsylvania Medical Society, Government 
Relations Department, at 1-800-228-7823, Ext. 1452. 
There is also another initiative, on the national level, which 
should interest physicians. 
The American Association of Orthopaedic Surgeons has 
created a 1-800 telephone number to allow individuals to 
contact members of the U.S. House of Representatives to urge 
them to co-sponsor H.R. 1304, the Quality Health Care 
Coalition Act (also known as the Campbell Bill). The 
legislation would allow physicians and other health care 
professionals to enter into negotiations with health care plans 
or other payers without violating antitrust laws. The telephone 
number is 1-888-812-8824. 
px~ 
Robert X. Murphy, Jr., MD 
Legislative Chairman 
Lehigh County Medical Society 
/ . ' :. · Gcisting~0Futid :e#ablished ·.· .. · · · · · · 
·=A ~fundw~·recentJ}' .e$taBlisn~d: to.·benefit .. · · 
.~o~ep~''W~:~tinger, Mt> ;,and· hi~'family~ .· If 
Y~LI w,ish t,()'tM.~e·a cor'ltr:(~uti~n~ pleCise'ft1~~ .. 
::yo~~ check·payoble. to~~Tfl~ J9~epb·,Gastinger 
Fund"·,and send.Jt~to:Beth Martin~ Mtdicdlv$toff 
, $ervlcesi ~ehigh}lalley .. Hospitat;.'CedhrcCrest'& · 
:I.:7B;·.RO:Box(~·a9;A'IIent.oM.m;'PA 181054f556;·"·' 
,:ffyo!J have anyqu~_tion$ ·please.'contaetMs · .. 
:Mar~i.r it. (610),4B2is9ao.. · ... · <: . _ · ·. · · · · 
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Gregory Brusko, DO, Named Vice 
Chairperson of Surgery at MHC 
At the June 1 Medical Executive Committee, Gregory Brusko, 
DO, was appointed Vice Chairperson of the Department of 
Surgery at Muhlenberg Hospital Center. 
A member of the Medical Staff since August, 1995, Dr. Bruske 
is a graduate of the Philadelphia College of Osteopathic 
Medicine. He completed his internship at Allentown 
Osteopathic Medical Center, followed by a four-year General 
Surgery residency at Grandview Medical Center, Dayton, Ohio. 
Dr. Bruske is certified by the American Osteopathic Board of 
Surgery. 
Dr. Brusko is a member of the practice of Toselli & Bruske 
Surgical Associates, LTD, with offices in Bethlehem and 
Allentown. 
At th~~General Medicc1rstaff~rneeting 1held on Mond~~-;:j 
iune:14, the f()llowingitems were approved: 
> The Medical Staff budget for fY 2006was. 
approved as present~d: ·_ · - . ; 
'> ·DueS' assessments for FY-2000wert.approved·a5 
foUows: 
Dentists- all active will beasse5sed$25p;OO 
Dentists - till associate will be asses'sed :$150.00 
··All: Other Active staffwil_l be-assessed '$350:0Q. · 
All•dfher :Associate staff will be assessed 
·:$'20o:oo ·.. _ . . ...• 
All members -of the M~dical :Staff who reachcthek : 
6'5fh birthday on or before September· t·~999 will . 
have their. dl.ies waived~< . · · · · 
-> · 111e designation of:Em~ri;tus was·elirni~atedfronr . 
the· Medical Staff: Bylaws .. This~deslg~aticm.~i~ply_ · -~ 
meansthatan in9ividuar'has reacf\~~"Ti1e:cag(or'65.'· 
in their: particulciJ;; ~t~pcy~ Appi"p~imately.tw9 
, years. ago I this was made:an •optioi'\Jor ,individuals,' . 
Since-this was an ag~,.relate~ ~e5igncifion rather . -· 
'than_academichonor,it wasfeltthat·there·was,no,c: 
loriger.a needf,or this/~refix to>staffcategocy. 
Outpatient Cardiopulmonary Rehab 
Department Opens at MHC 
Muhlenberg Hospital Center is pleased to announce the 
opening of the outpatient Cardiopulmonary Rehabilitation 
Department. This new service is located on the first floor near 
the visitors' lobby entrance and is easily accessible for 
patients. 
The Cardiopulmonary Rehabilitation Department offers the 
following programs and services: (~ 
• Phase II Monitored Cardiac Rehabilitation 
• Phase Ill Supervised Cardiac Rehabilitation 
• Pulmonary Rehabilitation 
• Vascular Rehabilitation 
• Employee Wellness 
• General Fitness 
• Participant education and support 
These programs are designed to enhance the recovery of 
post-CABG, post-MI, and post-revascularization patients, as 
well as improve functional capacity and symptom management 
in patients battling chronic disease conditions such as COPD, 
asthma, coronary artery disease, and peripheral vascular 
disease. 
Program participants work with a team of clinicians including 
registered nurses, respiratory therapists, and exercise 
physiologists to develop a lifelong habit of positive lifestyle 
behaviors through specific, individualized treatment strategies. 
Most of the programs require a physician order and pre-
admission requirements prior to program commencement. 
Insurance coverage varies and is based on the policies of each 
specific plan. 
For patient referrals, more detailed program ( 
information/requirements, facility tours, or to request 
brochures, please call the Cardiopulmonary Rehabilitation 
Department at (610) 861-2559. If you are interested in having 
an informational presentation conducted for your office staff or 
colleagues, please contact Terri Falcone, Program 
Coordinator, at (610) 861-2559 or through e-mail. 
Parking Changes/ 
Construction to Begin at 
MHC 
Approval was recently received to 
begin Phase I construction of a new 
two-story psychiatric facility and a central utility building . 
located on the campus of Muhlenberg Hospital Center. Due to 
this construction, which is scheduled to begin in mid-July, a 
series of parking changes will be necessary. When ground is 
broken to begin construction, the Physical Therapy lot will 
close. However, additional spaces will be constructed to 
accommodate employee and physician parking. 
Stay tuned for additional information as it becomes availablf( 
If you have any questions regarding this issue, please contab. 
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Implementation of IRS Fees 
Rega~ing future new protocol submissions, the Lehigh Valley 
Hosp1taUMuhlenberg Hospital Center Institutional Review 
Board (IRB) will charge a $1,000 per protocol processing fee to 
reimburse for overhead costs (protocol registration, file 
maintenance, annual renewal, etc.). Any fees received beyond 
overhead costs will be placed into a fund for resident research. 
This policy becomes effective on July 1, 1999. 
THIS POLICY APPLIES TO DEVICE· AND DRUG 
COMPANY-SPONSORED PROTOCOLS ONLY. In-house, 
student and other staff protocols are exempt. 
Please include this fee in your budget as either an "indirect 
hospital expense• or as a line item fee for IRB review , 
especially if the sponsor already allows for this in their 
paperwork. 
THIS POLICY DOES NOT AFFECT PROTOCOLS IN 
PROGRESS. If you have already finalized your budget, but 
have not yet submitted the study for IRB review, these 
protocols are exempt as well. 
CLINICAL TRIALS PROTOCOLS will have a separate fee 
schedule, which is yet to be determined. 
Also, consent forms will NOT require a separate financial 
disclosure/conflict of interest statement If you need a copy of 
the IRS's current Consent Form Template, please contact 
Bernadette Glenn, IRB Coordinator, at (610) 402-2529. 
If you have any questions or concerns regarding this issue, 
please contact Bernadette Glenn at (610) 402-2529 or Tom 
Wasser, IRB Administrator, at (610) 402-2497. 
LVH Joins Second Major Breast Cancer 
Prevention Trial 
Lehigh Valley Hospital's John and Dorothy Morgan Cancer 
Center is participating in one of the largest breast cancer 
prevention studies ever, joining more than 400 other medical 
centers in the United States, Canada and Puerto Rico. 
The Morgan Cancer Center, which is also operating the Study 
of Tamoxifen and Raloxifene (STAR) at Muhlenberg Hospital 
Center, Gnaden Huetten Memorial Hospital, and Hazleton 
General Hospital, is looking for women to join the study. 
. STAR ~ill 7xamine ~hether the osteoporosis drug raloxifene 
IS effective m preventing breast cancer in women who are at 
high risk for the disease and whether it offers benefits over 
tamoxifen, the drug of choice. In the first Breast Cancer 
Prevention Trial, in which the Morgan Cancer Center also 
participated, tamoxifen showed a reduced chance of 
developing breast cancer by about half. 
"Studies of raloxifene suggest it has the potential to prevent 
breast cancer,• said Elisabeth Ladd, director of Breast Health 
Services. "The only way to prove that potential is to do a 
clinical trial in which the risks and benefits of raloxifene are 
directly compared with the risks and benefits of tamoxifen. • 
Women who participate must be postmenopausal, at least age 
35, and have had an increased risk of breast cancer 
dete~in~ by their family history of breast cancer, personal 
med1cal h1story, age at first menstrual period and age at first 
live birth. 
"Tell your family, your friends and your patients who might be 
eligible about this study, • said Andrea Geshen, manager of the 
Morgan Cancer Center's clinical services. "Because there is 
no placebo, everybody who participates has the potential to 
benefit." 
On~e a wom~n chooses to participate, she will be randomly 
ass1gned to either 20 mg tamoxifen or 60 mg raloxifene daily 
~or fiv~ years and will have regular follow-up examinations, 
mcludmg mammograms and gynecologic exams. 
Up to 22,000 women nationwide are expected to be enrolled 
in this double-blind, randomized clinical trial. 
T ~moxifen has been used for almost 25 years to treat patients 
with advanced breast cancer, and since 2985 as an adjuvant 
or follow-up therapy after radiation and/or surgery for early-
stage breast cancer. In October, the Food and Drug 
Administration approved it for breast cancer prevention. 
Women interested in participating can be seen at the 
participating hospital closest to them. For more information 
about the trial, call1-877-548-3805. 
.. ,,_.., 
r-':/.. . ~: .. ~. ' .· ·:.: 
Peb~idernents ~: Due to a:.~he1119e:oir. the docu~entatiori 
~ requirements. ~or .debridem~nts,:•sharp;Qeb~lderilent• 
· can no longer~ be eoded t() EJ<cisioncil :Deb'r,ideme~t·. · · 
' .· ~ 
Iri' order to code'Exdsiona! D~bria~ment; the word 
'·eXcisional• must. be documented . 
.,. . .. · ' ··. ' ... 
·;'· 
Ifyo~'n(lve any questlo'ns;please·contact bill" ina Kutish · ···· .. 
',~VJ1;~?dir!1 Teafl) ~~er~at {6i9>;~0i;.2319, or Betty I 
,:Dieter~:MHCCO~JI'I9:Team.~der;, 1at~{610)86h8384. · 
'· ' ·. . '., .. , ... ,.,.,,,.·, :· o·.; ::·.:·: ,''·"·· . 
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4A to Accept Higher Level Acuity 
Patients 
Beginning July 13, 1999, patient care unit 4A, located at Cedar 
Crest & 1-78, will be able to handle higher level acuity patients. 
Initially, the unit will accommodate up to four patients who may 
require IV antiarrhythmic medications, nitroglycerine, 
dopamine, or dobutamine. These patients are the type you 
would admit to PCCU. In mid-August, 4A will be able to 
handle eight higher level acuity patients. The need for a 
further increase in number will be evaluated in September. 
When this change occurs, PCCU will then keep up to four 
patients on Med-Surg status. The goal of this plan i~ to 
decrease patient transfers, increase patient satisfaction, and 
increase the availability of low level monitored beds at Cedar 
Crest & 1-78. 
If you have any questions regarding this issue, please contact 
Molly Sebastian, Director, ACUIPCCU, at (610) 402-8723, or 
Bruce A. Feldman, DO, Medical Director, 4A, at (610) 433-
6442. 
Work Flow Analysis Initiative to be 
Rolled Out in Patient Care Services 
In mid July, Phase I of a Work Flow Analysis project, 
sponsored by Care Management Council, will be rolled out in 
Patient Care Services. 
The purpose of this initiative is twofold: 
1. To evaluate if systems are in place and operating at 
optimum levels to assure service excellence and 
innovation. 
2. To determine whether the right people are in the right 
place, doing the right work, and the right time, for 
delivering quality, cost effective care. 
The specific goals are: 
1. To understand the efficiency and productivity of 
designated processes, structures and job roles that impact 
quality. 
2. To understand the workload and determine the issues 
which drive the work. 
3. To understand the roadblocks that prevent quality service 
by department or role. 
Succinctly stated, this initiative is focused on understanding 
"the work" of care delivery and the processes to deliver the 
work, as well as identifying, quantifying, and eliminating non-
value added activities. Strategies to be employed include 
Work Sampling, Focus Groups, and Roadblock Assessme( 
Phase I, which will be rolled out consecutively on two · 
Medical/Surgical units- 6B at Lehigh Valley Hospital, and 2S 
at Muhlenberg Hospital Center (July and August, respectively) 
- involves work sampling, a technique used to observe work 
activities and estimate the proportion of time spent in a given 
activity. This strategy provides an initial analysis of work 
activities and clarifies what activities are being done by each 
job function. Work Sampling will be followed up by Focus 
Groups and Roadblock Assessments. Preliminary analyses 
will begin in early August, and additional analyses and reports 
should be completed for both sites by early October. All 
together, these initial results will serve as a guide in identifying 
work activities that require further "drill down" analyses, as well 
as provide clarification for next steps. 
For more information regarding this project, please contact 
Yvonne Bryan, PhD, RN, Researcher, Patient Care Services, 
at (610) 402-1704, or Deborah Halkins, Management 
Engineer, at (610) 317-4842. 
Helwig Diabetes Center of Excellence 
The Helwig Diabetes Center of Excellence, a component o( 
Circulatory Center, is a new initiative of Lehigh Valley Health 
Network, which is being designed to meet the increasing 
health care needs of individuals with diabetes in our hospital 
and community. The goal of the center is to move from a 
traditional episodic model of education to a multi-dimensional 
comprehensive model, which will facilitate measurable 
improvements in the health status of this population. 
Currently, there are several diabetes services available, 
however, many of these services function independently of one 
another. The new initiative is designed to pull all of our 
existing services together to facilitate collaboration and allow 
patients to access care in an easier fashion. The Diabetes 
Center of Excellence model will occur in a virtual sense, 
however, without moving services. Existing services will be 
augmented through the addition of new and innovative 
programs that will include emphasis in the areas of prevention, 
disease management, and research. 
Ane$thesia PediatriC: Pre;.,edltati~no~ders •. ·· 
;;For'rri #:Do 164: 1~ are nQW:~yililab'ft through. · 
)he Cof1Solidated .. Grap~i~·Pi~ ~:·F>:acforma~·a·. 
:,.,Yrite~il'l em theform: :nji~~ are~50;form~·per , · 
~ PQCk. .. '; > . . . 
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Health Spectrum Pharmacy Services-
Meeting the Needs of Your Patients 
An Overview of Patient Care Services for the 
Prescriber 
Scope of Services 
Health Spectrum Phannacy Services was founded in 1986 to 
provide high quality, specialized phannaceutical care to the 
region that it serves. In addition to traditional prescription 
services, Health Spectrum is able to provide your patients with 
a full line of ostomy care products as well as an extensive 
assortment of orthotic appliances and supplies coordinated by 
certified fitters. Through Health Spectrum Medical Products, 
the needs of patients in skilled nursing facilities with 
pharmacotherapy as well as medical equipment needs can 
also be met. 
Health Spectrum Infusion Services can provide you with the 
option of specialized infusion therapies in the comfort of the 
patient's residence -whether they live at home or in an 
institutional setting. In the latter case, Health Spectrum 
specialists will coordinate the care of the patient with the 
housestaff. They work closely with a large number of 
professional nursing agencies. The network of care which 
results allows your patients to utilize parenteral or inhalation 
therapies in an environment conducive to healing -the 
patient's own environment. 
Specialized Infusion Therapies 
One of the hallmarks of the services provided by Health 
Spectrum Phannacy is specialized infusion therapies. 
Appropriately evaluated patients may be candidates for these 
services in the comfort of their homes. These services include, 
but are not limited to, the following: 
Parenteral Nutrition 
Hydration Therapy 
Parenteral Pain Management 
Anti-infective Therapy 
Immune-enhancing Infusions, such as Intravenous 
Immune Globulin 
Antihemophilic Factor Infusions 
Cancer Chemotherapy 
Inotropic Drug Infusion 
Terbutaline Infusion 
Immunosuppressant Therapy 
Health Spectrum's Nurse Specialists are certified in the 
{ insertion of Peripherally-Inserted Central Catheters (PICC) 
. lines. Insertion of this type of vascular access can greatly 
enhance the quality of the parenteral therapy chosen by 
decreasing the number of times the patient must be stuck to 
infuse the required therapy. Also, PICC lines allow the 
administration of solutions with high osmolarity (Parenteral 
Nutrition) or with high incidence of venous irritation and 
phlebitis (Vancomycin, Nafcillin) by allowing central venous 
administration of these therapies. PICC lines provide a 
valuable option in the management of your patients. 
Infusion Phannacists, as well as nursing personnel, are 
available 24 hours a day, seven days a week, to address the 
needs of your patients. Care is coordinated between Health 
Spectrum and the various nursing agencies utilized to provide 
the highest level of patient care. Health Spectrum Phannacy 
Services is accredited by the Joint Commission for the 
Accreditation of Healthcare Organizations (JCAHO). 
Insurance and Payment Issues 
Health Spectrum Phannacy Services will investigate all 
aspects of reimbursement for the services that you order for 
your patients. Whenever possible, the cost of therapy to the 
patient will be spelled out prior to the initiation of services. 
Health Spectrum Phannacy Services is a preferred provider for 
many commercial insurance programs, and their 
Reimbursement Specialists are available to answer any 
questions that arise regarding the patient's responsibilities for 
payment. 
If you have a patient who requires specialized infusion services 
or the need for a progressive phannacy practice, please 
contact Howard C. Cook, Jr., RPh, Clinical Phannacist, Health 
Spectrum Phannacy Services, at (61 0) 402-1968 or (800) 283-
7479. 
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Lehigh Magnetic Imaging Center Update 
New Open MRI Scanner 
Lehigh Magnetic Imaging Center (LMIC) is pleased to 
announce the availability of its new open MRI system, the 
Picker Proview. This new scanner represents the most 
advanced, innovative technology available. The Proview 
scanner produces the highest quality images at reduced 
scanning times. 
Key Advances 
MRI image quality is based upon key components including 
gradient strength, post processing software, and specialized 
imaging coils. The new open unit has the highest gradient 
strength of any open MRI system. Strong gradients not only 
improve image quality but also decrease scanning times. The 
software will allow for faster computer reconstruction of MRI 
images which further reduces scanning times. MRI imaging 
requires the use of coils that send and receive signals that 
produce the image. Advances in technology have produced 
an array of new, innovative coils that LMIC has acquired as 
part of the new scanner acquisition. 
Most "Open" Scanner Available 
The unique design of this open MRI unit provides the most 
accessibility of all open MRI systems in the Lehigh Valley by 
utilizing a c-arm design that is totally open on three sides of the 
patient. The design of the scanner provides a comfortable 
scanning environment for large and claustrophobic or anxious 
patients. The patient enters the scanning area by a side entry' 
approach, which alleviates the anxiety often associated with 
head-first entry of claustrophobic patients into the scanning 
area. 
Specially Designed Suite 
The design of the open MRI suite offers a spacious room, large 
windows overlooking a landscaped view, and ceiling skylights 
to allow natural light into the suite. Additional seating is 
available for friends or family members who wish to 
accompany the patient during the scan. 
The new open MRI scanner at LMIC is now available for 
patient appointments. To schedule an appointment for the 
new open scanner or the high field scanner, please call Lehigh 
Magnetic Imaging Center at (610) 740-9500. To arrange a 
tour of the facility, please call Kathy Adams, Director of 
Marketing, at (610) 740-9733. 
Look LMIC Up on the Web 
More information about the open Proview system, including 
equipment photos and MRI images, can be found at LMIC's 
newly-created web page. Type in the address -
www.LehighMRI.com to learn more about special patient 
services, the staff- including the interpretation specialties oj 
LMIC's radiologists -the state-of-the-art MRI scanners, bill( 
and insurance information, and much more. · 
The web site also provides a detailed look at what patients can 
expect during their MRI visit, from the time the appointment is 
made through how their doctor will receive the results. 
Knowing this information ahead of time can make a first-time 
MRI appointment much more pleasant. 
Collectibles Wanted for Walk-Through 
History Display 
Attention all physicians! The 1001h Anniversary Committee 
would like to solicit your help. They are looking for archival 
collectibles or medical memorabilia, such as surgical 
instruments and antiquated medical equipment, that may be 
borrowed to put on display during the 1 OQih Celebration and 
Walk-Through History Exhibit. This exhibit is being 
professionally built by designers Bill Kreider and Drew Francis, 
and coordinated by Sheryl Hawk of Public Affairs. It will be 
open to the public in September during the Senior Horizons 
and Nite Utes special events to be held in Agricultural Hall at 
the Allentown Fairgrounds. 
All items will be safeguarded and returned to you following ''" 
exhibit. For more information, please contact Sheryl Hawk, 
Public Affairs, at (610) 317-4816. 
News from the Pool Trust 
The Dorothy Rider Pool Health Care Trust is pleased to 
announce the addition of Ronald C. Dendas as a program 
officer primarily responsible for grant management for the Pool 
Trust. 
Prior to joining the Pool Trust, Mr. Dendas was executive 
director of AIDSNET, the regional planning coalition and fiscal 
agent for HIV/AIDS related services in a six-county area. 
AIDSNET helped develop, network and fund not-for-profit 
social service organizations providing care to people living with 
or at risk to become infected with HIVIAIDS. He was 
responsible for helping these agencies establish stronger fiscal 
management practices and outcome-based services. Prior to 
AIDSNET, Mr. Dendas was the executive director of the 
Schuylkill County Drug and Alcohol Executive Commission. 
A native of Nazareth, Pa., Mr. Dendas received a Bachelor ( 
Science degree in Criminal Justice from St. Anselm College ur 
New Hampshire and a Master of Science in Human 
Organization Science from Villanova University. 
( 
( 
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Press Ganey Results for April, 1999 
In an effort to keep physicians informed of how they are rated 
by patients in the Press Ganey reports, beginning with this 
issue of Medical Staff Progress Notes, physician ratings will 
be published each month. The Inpatient Monthly Report for 
April, 1999 is as follows: 
This Period 











Time Physician spent with you 
Physician concern questions/worries 
Physician kept you informed 
Friendliness/courtesy of physician 89.0 
92.1 Skill of physician · 
In addition to the above ratings, following are a number of 
comments made by patients regarding their physicians: 
~ All nurses and Dr. Gertner were highly professional and 
kind towards my baby and myself. 
~ Dr. Jung and his assistant were wonderful. They 
explained everything clearly and made me feel much more 
at ease. 
~ The anesthesia doctor and operating room nurses were 
cheerful and kind. Explained everything to me. They 
could not be any better. Just wonderful! They put me at 
ease. 
~ Anesthesia doctor was beyond excellent. Her name was 
Serena. 
~ Dr. Radio was excellent in my case during labor and 
delivery. 
)> Dr. Smolinski was just Super! He explained everything to 
me and also made me laugh when it was tough to laugh. 
)> Dr. Olex was great, tool 
~ Dr. D'Angelo continues to exceed my expectations. Wish 
all doctors would follow his personable, comforting, caring, 
down-to-earth interaction with the patient. 
~ Dr. Brett Godbout is excellent. He thoroughly answered 
all questions in a way I could understand. He told me 
what to expect after the operation and what I could hope 
to accomplish. 
)> Dr. Robert P. Marcincin is tops in his field, and his bedside 
manner is excellent. 
)> Dr. Gina Karess is a great person. 
)> Dr. Joe Guzzo- wonderful, wonderful. 
)> Dr. James Kintzel was very responsive to my needs and 
did not hesitate to make me feel better. 
)> Dr. Karper works very well with me. He is super. 
Congratulations! 
Kevin E. Glancy, MD, Division of Trauma-Surgical Critical 
Care/General Surgery, was recenHy approved for 
reappointment as a Fellow of the American College of 
Emergency Physicians. 
Serena A Jung, MD, Department of Anesthesiology, was 
recently certified by the American Board of Anesthesiology. 
Larry N. Merkle, MD, Chief, Division of Endocrinology/ 
Metabolism, was elected Vice Chairman of the Pennsylvania 
Diabetes Academy, an affiliate of The Foundation of the 
Pennsylvania Medical Society since 1984, at the recent Board 
of Directors meeting. In addition, he was recently honored by 
the Lehigh Valley Chapter of the Amertcan Diabetes 
Association at their Third Annual Dinner Dance and Silent 
Auction held at the Allentown Hilton on April16. 
Papers, Publications and Presentations 
Wayne E. Dubov, MD, Division of Physical 
Medicine/Rehabilitation, presented "Successful Alternatives to 
Benzodiazepines for Agitation" at the recent Medical College of 
Virginia's 23rd Annual Cognitive, Neuromedical and Behavioral 
Aspects of Brain Injury Conference. The paper was co-
authored by Peggy E. Showalter, MD, Department of 
Psychiatry; Deborah N. Kimmel, MD, Division of Physical 
Medicine/Rehabilitation, and Dr. Dubov. 
In addition, Drs. Kimmel and Showalter co-authored two 
articles which were presented as poster presentations at the 
June meeting of the World Congress on Brain Injury held in 
Quebec, Canada. The poster presentations included 
"Alternative Medications for Agitation, Anxiety, Insomnia, and 
Irritability Symptoms following Brain Injury," and "Beyond 
Agitation: Psychiatric Diagnosis of Patients with Agitated 
Symptoms Resulting from Brain Injury." 
Mark A Gittleman, MD, Division of General Surgery, was an 
invited speaker at the Texas Health Research lnstiMe for the 
symposium, "Minimally Invasive Technologies: Medicine in the 
21st Century," which was held on May 14 at Presbytertan 
Hospital of Dallas in Dallas, Texas. Dr. Gittleman was also an 
invited speaker at the 21st New York State Surgical 
SymP.Qsium on May 22 in Cooperstown, New York. He 
lecturlKI on "Image Guided Breast Biopsy." 
(Continued on Page 10) 
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(Continued from Page 9) 
Larry R. Glazerrnan, MD, Division of Primary Obstetrics and 
Gynecology, participated in a debate on "Hysterectomy vs. 
Hysteroscopy for Abnormal Uterine Bleeding" at the 47th 
annual clinical meeting of the American College of 
Obstetricians and Gynecologists which was held May 19 in 
Philadelphia. 
William F.lobst, MD, Division of Rheumatology, had his 
project abstract, "Rheumatology as a Longitudinal Curriculum," 
published in the spring edition of the MedEd News of the 
Office of Educational Development at Harvard Medical School. 
This project was the focus of Dr. lobst's endeavors as a 
scholar in the Harvard Macy Institute Program for Physician-
Educators during 1998. He was invited to retum to the 
program in 1999 as a faculty member. The program is 
sponsored by Harvard Medical School and the Harvard 
Graduate School of Education. 
Masayuki Kazahaya, MD, Division of Ophthalmology, and 
Glen L. Oliver, MD, Chief, Division of Ophthalmology, both 
attended the Central Pennsylvania Retinal Society meeting on 
May 7 in Hershey. Dr. Kazahaya presented a case report on 
management of intraocular glass foreign body removed by 
pars plana vitrectomy. Dr. Oliver presented a case report on 
drainage of preretinal hemorrhages by YAG laser 
photodisruption. 
Thomas D. Meade, MD, Division of Orthopedic Surgery, was 
an invited lecturer at a conference held in Bermuda sponsored 
by the Rothman Institute and Biomet titled "Crucial Decisions 
in Total Joint Arthroplasty and Sports Medicine." Dr. Meade 
presented three talks including "Technical Pear1s in Performing 
Anterior Cruciate Ligament Reconstructive Surgery, • "Clavicle 
and AC Joint Injuries in Athletes Operative Options, • and "The 
Lateral Approach to the Valgus Knee for the Recreational Total 
Joint Surgeon." 
Larry N. Merkle, MD, Chief, Division of Endocrinology/ 
Metabolism, authored an article, "Landmark Diabetes Studies 
Make a Difference,• which was published in the June, 1999 
issue of Pennsylvania Medicine. 
Khawaja Azi Muddin, MD, colon and rectal surgery resident, 
and lndru T. Khubchandani, MD, Division of Colon and 
Rectal Surgery, co-authored the article, "Current Options in the 
Surgical Management of Ulcerative Colitis," which was 
published as the lead article in Volume 18 of the Indian 
Journal of Coloproctology. 
In addition, Dr. Muddin presented ·urocolonic Neoplasia: 
Uncommon Entity - Difficult Managemenr at the American 
Society of Colon and Rectal Surgeons meeting in May. This 
paper was co-authored by Dr. Khubchandani, John J. Stasik, 
MD, Chief, Division of Colon and Rectal Surgery; Lester 
Rosen, MD, Associate Chief, Division of Colon and Rectal .. 
Surgery; and Robert D. Riether, MD, Colon and Rectal ( 
Surgery Residency Program Director. · 
Craig R. Reckard, MD, Chief, Section of Transplantation 
Surgery, was an invited speaker at the American Society for 
Histocompatibility and Immunogenetics (ASHI) Regional 
Education Workshop that was held May 5-7 in Allentown. Dr. 
Reckard spoke on various aspects of "The Clinical 
Management of a Sensitized Patient. • 
Upcoming Seminars, Conferences and 
Meetings 
L TACH Informational Sessions 
Two Medical Staff informational sessions have been scheduled 
to provide an overview of the long-term acute care hospital 
(L TACH) that Good Shepherd Rehabilitation Hospital will own 
and operate at Lehigh Valley Hospital. 
The sessions will be held as follows: 
Tuesday, July 13 
~~~orium, Lehigh Valley Hospital, Cedar Crest & 1-78 ( 
Tuesday, July 20 
6p.m. 
Classroom 1, Lehigh Valley Hospital, Cedar Crest & 1-78 
Jane Dorval, MD, Chief, Division of Physical Medicine & 
Rehabilitation; Stephen C. Matchett, MD, Division of 
Pulmonary Medicine; and Linda Dean, LTACH Hospital 
Operations, will provide the overview and be available to 
answer questions. 
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Keith R. Doram, MD 
LVPG-Medicine 
Lehigh Valley Hospital 
Cedar Crest & 1-78 
P.O. Box689 
Allentown, PA 18105-1556 
(610) 402-8200 
Fax: {610) 402-1675 
Deparbnent of Medicine 
Division of General Internal Medicine 
Provisional Active 
Site of Privileges: LVH & MHC 
Tayyaba S. Jan, MD 
(Solo practice) 
7615 Tilghman Street 
Fogelsville, PA 18051 
(610) 366-9990 
Deparbnent of Pediatrics 
Division of General Pediatrics 
( Provisional Active 
Site of Privileges: LVH & MHC 
Michael J. Nlmeh, DO 
Primary Care Associates in the LV, PC 
1028 N. 19111 Street 
Allentown, PA 18104-3762 
(610) 437-1288 
Fax: (610) 432-6517 
Deparbnent of Medicine 
Division of General Internal Medicine 
Provisional Active 
Site of Privileges: LVH & MHC 
Janet L Osborne, MD 
Lehigh Valley Women's Cancer Center 
1611 Pond Road 
Suite 101 
Allentown, PA 18104-2256 
(610) 366-8555 
Fax: (61 0) 366-8550 
Department of Obstetrics and Gynecology 
Division of Gynecology 
Section of Gynecologic Oncology 
Provisional Active 
Site of Privileges: MHC 
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Steven J. Svabek, DO 
Coordinated HeaHh Systems 
2775 Schoenersville Road 
Bethlehem, PA 18017-7326 
(610) 861-8080 
Fax: (610) 865-2761 
Department of Surgery 
Division of Orthopedic Surgery 
Provisional Active 
Site of Privileges: MHC 
John B. Villeneuve, MD 
Lehigh Valley Women's Cancer Center 
1611 Pond Road 
Suite 101 
Allentown, PA 18104-2256 
(610) 366-8555 
Fax: (610) 366-8550 
Department of Obstetrics and Gynecology 
Division of Gynecology 
Section of Gynecologic Oncology 
Provisional Active 
Site of Privileges: MHC 
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Appointment to Medical Staff Leadership Position 
Lawrence W. Bardawll, MD 
Associate Chief 
Division of Gastroenterology 
Keith R. Doram, MD 
Chief 
Division of General Internal Medicine 
Robert Kricun, MD 
Chairperson 
Department of Radiology/Diagnostic Medical Imaging 
Address Change 
Nora A. Suggs, MD 
1230 S. Cedar Crest Blvd., Suite 303 
Allentown, PA 18103-6212 
(610) 439-4108 
Fax: (61 0) 435-5003 
Practice and Address Changes 
Mark C. Lester, MD 
LVPG-Neurosurgery 
1240 S. Cedar Crest Blvd., Suite 305 
Allentown, PA 18103-6264 
(61 0) 437-4911 
Fax: (610) 820-5357 
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Russell J. Rentler, MD 
(Solo Practice) 
6083 HamHton Blvd. 
Wescosville, PA 18106-9767 
(610) 530-7712 
Fax: (610) 530-1921 
Thomas J. Tachovsky, MD 
Cancer Care Associates 
830 Ostrum Street 
Bethlehem, PA 18015 
(610) 954-2140 
Fax: (610) 954-3583 
Status Changes 
Arthur A. Altman, MD 
Department of Pathology 
Division of Clinical & Anatomic Pathology 
From Provisional Active to Honorary 
Russ S. Bergman, DMD 
Department of Dentistry 
Division of General Dentisby 
From Provisional Associate to Provisional Active · 
Site of Privileges: LVH & MHC 
Arnedeo DiEdwardo, DDS 
Department of Dentistry 
Division of General Dentisby 
From Associate to Provisional Active 
Site of Privileges: LVH & MHC 
Martin L. Leymeister, DMD 
Department of Dentisby 
Division of General Dentistry 
From Associate to Provisional Active 
Site of Privileges: LVH & MHC 
Brent M. Nicklscher, DO 
Department of Medicine 
Division of General Internal Medicine 
From Provisional Active to Active 
Site of Privileges: LVH & MHC 
Lauri Passeri, DMD 
Department of Dentistry 
Division of General Dentistry 
From Associate to Provisional Active 
Site of Privileges: LVH & MHC 
Gary G. Peters, DDS 
DepartrnentofDentisby 
Oivision of General Dentistry 
From Associate to Provisional Active 
Site of Privileges: LVH & MHC 
Joseph H. Schaffer, DDS 
Department of Dentistry 
Division of General Dentistry 
From Associate to Provisional Active 
Site of Privileges: LVH & MHC 
Ruth Ann Spears, MD 
Department of Family Practice 
From Affiliate to Honorary 
Thomas J. Tanzosh, DMD 
Department of Dentistry 
Division of General Dentisby 
From Associate to Provisional Active 
Site of Privileges: LVH & MHC 
John C. Worsley, DMD 
Department of Dentistry 
Division of General Dentistry 
From Associate to Provisional Active 
Site of Privileges: LVH & MHC 
Yelena M. Yermak, MD 
Department of Psychiatry 
( 
( 
From Division of Psychiatric Ambulatory Care/Adult Inpatient 
Psychiatry 
To Division of Consultation/Liaison Psychiatry 
From Provisional Active to Active 
Site of Privileges: LVH & MHC 
Leave of Absence 
Dennis W. Kean, MD 
Department of Pediatrics 
Division of General Pediatrics 
From Active to Active/LOA 
Site of Privileges: LVH & MHC 
Resignations 
Manuel H. Espinosa, MD 
Department of Surgery 
Division of General Surgery 
Active 
( 
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Humberto J. Gonzalez, MD 
Department of Psychiatry 
Associate 
Bruce M. Greenspan, MD 
Department of Surgery 
Division of Otolaryngology-Head & Neck Surgery 
Associate 
. Gary J. Heckenberger, DDS 
Department of Dentistry 
Division of General Dentistry 
Associate 
Robert C. Hunsicker, MD 
Department of Surgery 
Division of Otolaryngology-Head & Neck Surgery 
Associate 
Gregory J. Menio, MD 
Department of Surgery 
Division of Orthopedic Surgery 
Associate 
Anthony F. Moscato, MD 
Department of Medicine 
( Division of General Internal Medicine 
Active 
( 
Glenn Moyer, MD 
Department of Surgery 
Division of Ophthalmology 
Active 
Lino A. Quilo, MD 
Department of Emergency Medicine 
Division of Emergency Medicine 
Active 
Timothy Scharle, MD 
Department of Medicine 
Division of General Internal Medicine 
Associate 
Melinda Toney, MD 
Department of Family Practice 
Active 
Steward G. Wolf, MD 
Department of Medicine 
Division of General Internal Medicine 
Emeritus Associate 
Allied Health Professionals 
Change of Supervising Physician 
Jennifer M. Knights, PA·C 
Physician Extender 
Physician Assistant- PA-C 
From: Theodore G. Phillips, MD- The Heart Care Group, PC 
To: Thomas D. Meade, MD- Orthopaedic Associates of 
Allentown 
Happy Fourth of July! 
lEHI&IVAILEY 
HOSPITAL 
THERAPEUTICS AT A GLANCE 
The following actions were taken at the May 1999 Therapeutics Committee Meeting -Clinical Pharmacy 
Services -Joseph Ottinger, R.Ph., MS, MBA, Christopher Moore, R.Ph., James Sianis, Pharm.D. 
Emesis Nemesis 
Scoring guidelines (based on Hesketh 
article) delineating the emetic potential 
of various chemotherapy drugs and 
combinations thereof (includes dosing 
considerations related to these agents) 
have been developed. Some recent 
data and the latest consensus guidelines 
from NCCN (National Comprehensive 
Cancer Network), MASCC 
(Multinational Association of 
Supportive Care in Cancer), ASCO 
(American Society of Clinical 
Oncologists), and ASHP (American 
Society of Health-System Pharmacists) 
appear to support the use of oral 
therapy for prophylaxis regimens in 
those patients able to tolerate them. 
This information has been utilized to 
modify previously codified anti-emetic 
therapy for certain prophylaxis 
regimens; and the treatment of selected 
"breakthrough"/"delayed" episodes of 
nausea and vomiting.. The changes are 
primarily related to the use of 
ondansetron vs granisetron orally and to 
reducing the intravenous doses of 
ondansetron in these selected instances. 
The following changes will be made to 
the existing "Antineoplastic Agent 
Order Sheet" when current supplies are 
exhausted. In the interim, the 
pharmacist will record the 
modifications to the antiemetic 
algorithm elaborated in the following 
sections: 
Sections C and D, Moderate 
Emetogenic Potential class , level 3-
replace oral Granisetron lmg BID or 
Granisetron 2 mg daily with oral 
ondansetron 16 mg for each day of 
chemotherapy. 
Decrease the dose of IV ondansetron 
to an 8 mg dose vs. the 16 mg dose 
currently listed. All other 
medications and their respective dosing 
will remain the same. 
Section E and F, High Emetogenic 
Potential class, level 4&5-substitute 
oral ondansetron 24 mg for each day 
of chemotherapy for oral Granisetron 
lmg BID or Granisetron 2mg daily. 
Substitute IV ondansetron at a 16 mg 
dose vs. the 24 mg dose currently 
listed. All other medications and 
their respective dosing will remain the 
same. 
In the Low Emetogenic Potential class 
TREATMENT section, substitute oral 
ondansetron 16mg daily for oral 
Granisetron lmg BID or 2mg ~ly. 
All other treatment choices will remain 
unchanged. 
Apply Sparingly 
In order to streamline the selection of 
topical steroid preparations and 
eliminate unnecessary "calls", an 
automatic substitution policy will be 
adopted. The product selection process 
was developed via the use of 
vasoconstrictor assay stratification of 
existing FDA-approved formulations. 
After identifying the "potency" 
classification of the topical product, a 
formulary preparation of similar type 
(e.g, ointment for ointment) will be 
substituted as indicated below. 
Relative Potency of Selected Topical 








Available agents Formulary Substitution 
Very High Potency 
Augmented betamethasone d.ipropionate oint. 0.05% 
Clobetasol propionate crJoint. 
Diflorasone oint. 0.05% 
Halobetasol propionate crJoint. 0.05% 
High Potency 
Amcinonide crJointO.l% 
Augmented betamethasone d.iproprionate cr. 0.05% 
Betamethasone diproprionate cr Joint. 0.05% 
Betamethasone valerate oint 0.1% 
Desoximetasone crJoint. 0.25% crJoint. 
Diflorasone diacetate crJoint. 0.05% 
Fluocinolone acetonide cr. 0.2% 
Fluocinonide crJoint. 0.05% 
Halocinonide crJoint. 0.1% 
Medium Potency 
Betamethasone benzoate cr. 0.025% 
Betamethasone valerate cr. 0.1% 
Clocortolone pivalate cr. 0.1% 
Desoximetasone cr. 0.05% 
Fluocinolone acetonide crJoint. 0.025% 
Flurandrenolide crJoint. 0.025% 
" 0.05% 
Fluticasone propionate cr. 0.05% 
" oint. 0.005% 
Hydrocortisone butyrate oint 0.1% 
Hydrocortisone valerate crJoint. 0.2% 
Mometasone furoate crJoint. 0.1% 





Aclometasone dipropionate crJoint. 0.05% 
Desonide cr. 0.05% 
Dexamethasone sodium phosphate cr. 0.1% 
Fluocinolone acetonide cr. 0.01% 
Hydrocortisone crJoint. lo/o-2.5% 









acetonide crJoint 0.1% 
Hydrocortisone 1% 
crJoint. 
Application directions will be continued as per the original physician order. 
($)Cost/gram 
$0.85/ gram 








$0.02/gram for cream 
$0.04/gram for oint. 
All Formulary agents are also available in topical lotions for those application to those areas not 
amenable to creams and ointments. 
All orders related to Dermatology consults will NOT be automatically substituted, but will require 
authorization from the prescriber. 
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SangCya Oral Solution 
The FDA has approved SangCya, a 
modified cyclosporine suspension. The 
product was given an AlB rating 
compared with Neoral suspension, 
indicating that the two products are 
considered bioequivalent. This 
preparation will be utilized in-hospital 
for all Neoral oral solution orders. 
Orders for other cyclosporine 
formulations will be dispensed as 
written. 
ADRReports 
ADR reporting continued to be fairly 
consistent for the last two quarters of 
1998. Total incidents were eighty-nine 
for the third quarter and eighty-eight for 
the fourth quarter. Phannacists and 
Nurses supplied about 90% of the 
reports. There was one death in the 3rd 
quarter and two deaths in the 4th quarter, 
where drug therapy may have 
contributed to the patients demise. 
Below are the particulars for these two 
quarters. 
3rd Quarter Data 




X-Ray Technician 6 
Physician ..1. 
TOTAL 89 















































































Fourth Quarter Data 







































Highly Probable _1 
TOTAL 88 





































A 'Singulair' moment 
Montelukast, a leukotriene antagonist, is 
approved for the prophylaxis and 
chronic treatment of asthma in adults 
and pediatric patients ( ;;:: 6 years of 
age), and it is available as a chewable 
tablet for children. It can be taken 
without regard to food and is 
administered once daily. ADR 
incidents and frequencies are similar to 
zafrrlukast (Accolate). Due to potential 
benefits in compliance, expanded 
indications, and lack of food-drug 
related absorption issues this agent will 
supplant zafirlukast on the Drug 
Formulary. Accolate orders for 20 mg 
BID will automatically be substituted 
with montelukast 1 Omg daily unless 
patients have had a documented 
'allergic' reaction to this product. 
Fast Track Additions-
May 
1bree "product extension" preparations 
were approved during this period. The 
extended release formulations of 
metoprolol (Toprol XL) and glipizide 
(Glucotrol XL) were added along with 
the "Diskus" inhalation system for 
Serevent. The Formulary will contain 
both the current MDI and ''Diskus" 
delivery systems for Serevent until 
further notice. 
Federal EPA directives will require use 
of non-fluoro/chloro-carbon propellants 
for all :MOl's at some 1mdetermined 
time. Several of the companies have 
developed insuffiation devices (Glaxo; 
Merck) while Schering-Key has opted to 
modify its propellant system. 
The "Diskus" device delivers the active 
drug via an inhalation powder. In the 
case of Serevent products, two "sprays" 
of the MDI product provide an 
equivalent dose (i.e., 50 meg) to one 









Transfusion Medicine -Informed Consent 
Pennsylvania Law Act 135, enacted January, 1997, requires that a separate informed consent be obtained from patients 
who are about to undergo planned or elective transfusion of blood or blood components. 
Informed consent is the process of a physician communicating with a patient about a proposed procedure or treatment. 
Documentation of this should be done in the patient's chart. The minimum elements of this informed consent process 
include: 
1. Patient should be informed of the reason for transfusion, i.e., purpose and the anticipated effect or benefit. 
2. Patient should be provided altemative(s) to transfusion. 
3. Patient should be made aware of the risks of transfusion. 
( The permission to be transfused must be obtained by a physician who has ordered the transfusion or designee. To assist 
you with this process, the following information will be available on all nursing units: 1) Physician Information Sheet with the 
current known risk factors and the expected incidence, 2) Patient Information Sheet (English and Spanish), and 3) Consent 
Form/Refusal Form. 
For a single admission, the consent needs to be obtained one time. However, when a patient is chronically transfused, the 
consent, once obtained, is valid for one year. Refer to the Transfusion Consent Policy (AD 6301.00) which is attached on 
Pages 21-24. 
Copies of the revised form, MRD-31, are available from Consolidated Graphics using a Pic N Pac requisition form (MM-35). 
For your information, a copy of MRD-31 is attached on Pages 25-30. 









POLICY NO:. AD 6301.00 
SUBJECT: Transfusion Consent 
EFFECTIVE DATE: November 1997 
AREAS AFFECTED: All Departments 
PAGE: I of 4 
It is essential that a transfusion consent form be obtained from all patients who are 
capable of giving consent or from a person authorized to consent on the patient's behalf 
prior to the patient receiving blood. If possible, this consent should be obtained in the 
physician's office prior to admission. 
Blood and blood products applicable to this policy include whole blood, packed red blood 
cells, fresh frozen plasma, platelets and cryoprecipitate. Consent must be obtained for the 
· transfusion of autologous blood; however, it is not needed for autotransfusion of salvaged 
blood. Transfusion consent/refusal is not needed for the administration of Factor VITI, 
Factor IX, Albumin, Hepatitis B lmmWle Globulin, or Intravenous Gamma Globulin 
(IGIV). 
If an emergency exists, consent is not required to transfuse blood to the patient at that 
time, however, a reasonable effort should be made to obtain consent in all cases. If 
consent is unable to be obtained for any reason; the patient's medical record should state, 
in detail, the efforts pursued, the nature of the threat to life or health including its 
immediacy and magnitude. Once the emergency subsides and additional blood is needed, 




A. Hospital Personnel - includes, but is not limited to, all employees, medical staff, 
allied health professional staff, students, volunteers, and others engaged in any 
activities at the hospital, excludini patients and visitors (JCAHO). 
IV. PRQCEDIJRE 
Action 
A. The policies and procedures outlined in the Consent 
Administrative Policy Number 2100.00 apply to the 











Policy No: AD 6301.00 Page: 2 of4 
Transfusion consent'Refusal Form will be obtained 
by the physician who has ordered the transfusion or 
his/her designee. The individual obtaining consent 
should explain the risks, complications, benefits and 
alternatives to transfusion as outlined in the Patient 
Information for Blood Transfusion Sheet and the 
physician Information for Blood Transfusion Sheet. 
The signature of a witness may be obtained. The 
witness is witnessing the patient's signature only. 
If the patient is unable to sign because of physical 
or mental incompetence or the patient is a minor, 
consent must be obtained from the person 
authorized to consent on behalf of the patient. 
In some cases, it may be necessary to secure consent · 
via the telephone. The consent procedure must be 
heard by one person other than the physician. The 
consent form should indicate that it is a telphone 
consent and the person who gave consent. The 
person listening to the conversation will sign the 
witness line. 
The consent/refusal for transfusion of blood and/or 
blood products must be signed by the patient prior 
to receiving blood and/or blood products. It is 
preferable to have the consent/refusal for 
transfusion signed before a type and cross match for 
blood is ordered. However, blood may be drawn for 
a type and cross match whether or not the consent is 
known to be signed. 
The consent form should ideally be signed in the 
physician's office when discussing the surgical 
procedure and the possible need for blood. When 
the consent form is signed in the physician's office, 
it is to be considered valid for 60 days prior to 



















Policy No: AD 6301.00 Page: 3 of4 
The consent form must be signed prior to sedating 
the patient. 
During a single admission, the consent for blood 
transfusion needs to be signed one time. 
When used in the outpatient settings, the Blood 
Transfusion consent form should be considered 
valid for one year. 
Prior to surgery, when a patient has had a type and 
cross match for blood, and the consent/refusal form 
has not been signed the patient will not be sent to 
the operating room until consent has been obtained. 
If the patient is going for an operative procedure 
and the attending physician does not feel it 
necessary to order a type and cross match for blood 
and the necessity for blood is not foreseen, a 
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Consent/Refos_al for Transfusion of Blood 
and/or Blood Products 
0 
Physician Information for Blood Transfusion 
0 0 Page25 
With the advent of increased medical and legal risks for patients receiving blood transfusions, it is essential that physicians ordering 
blood transfusions thoroughly advise patients of the potential risks involved. In emergency situations where the patient cannot 
complete the fonn, the treatment note in the medical record indicating the number of units transfused and reason needed should 
suffice as lnfonned Consent cannot be secured after the fact. Once the emergency situation concludes, but the patient requires 
additional units of blood, consent should be obtained. 
Physicians obtaining lnfonned Consent should set aside ample time to meet with the patient and/or authorized person to advise 
them of risks and alternatives, and answer any questions prior to obtaining the signature on the consent fonn. 
The accompanying Patient Information Sheet for Blood Transfusion should be given to the patient for their review. The 0 risks listed should be discussed with the patient and/or authorized person along with any additional risks that you feel 
should be addressed. In describing and explaining the risks of blood transfusion, the information contained below may be 
useful. It should be noted that the incidence, as pointed out below, is a very close approximation from the literature as it 
exists today. We will update these if significant changes take place in the future. 
(_) 
Patient and/or authorized person should be infonned of the following infonnation relating to the risks of blood transfusion: 
• The possibility of needing a transfusion. 
• Approximate number of transfusions that can be expected during the course of the medical treatment. 
• Type of blood used and risk of each type. 
• An understanding of what medical action is recommended. 
• The associated risks and benefits of transfusion. 
• Alternative methods of therapy available including pre-deposit autologous transfusion, intraoperative salvage, 
isovolemic hemodilution, and directed donation. 
• The possible consequences of not receiving the recommended therapy. 
• An opportunity for the patient and/or authorized person to ask questions. 
0 Lastly, have the patient and/or authorized person sign the consent fonn if he I she decides to accept or refuse the transfusion. 
The risks may be immediate or long tenn, and include both immunologic and infectious disease consequences. Areas of particular 
importance are: 
• Hemolytic transfusion reaction. Incidence is 1 in 25,000 with a fatal incidence being 1 in 1 ,000,000. 
• Transmission of infectious diseases. Incidence for: HIV infection, 1 in 500,000; Hepatitis C, 1 in 100,000; 
Hepatitis B, 1 in 60,000; HTLV, 1 in 600,000. 
• Febrile reactions. Incidence 1 in 100. 
• Allergic reaction. Incidence 1 in 300. 
~ Circulatory overload reactions. 
• Bacterial contamination, e.g. Yersinia Enterocolitica < 1 in 1,000,000 for red cells; 1 in 10,000 for platelets. 
• Immune problems such as antibody fonnation. 
In regards to autologous transfusion as an alternative to •community blood" please explain this option and clearly infonn patients 
that for elective surgery, this is an acceptable and desirable alternative if the patient meets the screening requirements and is a 
suitable candidate. You, in concert with the Blood Bank Medical Director, make that decision. 
( ) . 
At Lehigh Valley Health Network directed donations and autologous donations are offered as alternatives to volunteer donor blood. 
The directed blood option, although available, is generally not encouraged by transfusion medicine specialists because the literature 
has not shown that this is a significantly safer alternative to community blood. 





HEAL Til NETWORK 
Consent/Refus_al for Transfusion of Blood 
and/or Blood PrOducts 
Patient Information Sheet for Blood Transfusion 
What Is It? 
Page27 
A blood transfusion is a treatment where someone receives blood or a part of blood from a donor. A donor is a person who gives 
some of their own blood to help another person who needs it. A person could receive blood for any of these reasons: 
• Blood lost during surgery • Illness which does not allow your 
• Blood clotting problems body to make its own blood cells 
• Shock • Injury 
When blood is taken from a donor, it is whole blood. Whole blood can be separated into parts which may be used to treat special 
blood problems. These blood parts or components, can be red blood cells (RBC's), plasma, platelets, and cryoprecipitate. 
Blood Types 
The most important blood group is ABO, which is divided into four types: 0, A, B, and AB. Each person is born with one of these 
blood types. The Rh factor is also one of the blood types. Your blood can either be Rh (+) or Rh (-). Both these factors (blood 
types and Rh) are used when matching your need for blood to a donor's blood. 
Safety of Blood 
There is no guarantee that the blood is 100% risk free. Before you receive donated blood, a sample of your blood will be tested to 
match the donor's blood. Although these measures are taken, bear in mind that a small group of patients may still react to the 
donor's blood. These symptoms may include: hives, fever, chills, breathing problems, itching, back pain, and wheezing. You will be 
carefully watched and cared for should you have a reaction. 
There is a slight risk of passing an illness or disease on to you, and problems can occur in the processing, preparing and giving of 
the blood. The major diseases known to be passed through the blood are viral diseases such as Hepatitis B, Hepatitis C, 
HIV(AIDS), Human T -cell Leukemia and Cytomegalovirus. There have also been rare cases of syphilis, malaria, and Hepatitis A 
reported. In these cases, the person who donates the blood is carrying the disease at the time of the blood donation. Please bear 
in mind that every effort is made to minimize these risks. These efforts include: careful screening of donors through medical 
history, and testing for the specific diseases. If the presence of a disease is detected in the blood, the blood is not used. 
Viral disease detection cannot be 100%. One reason for this is the "window of time" between getting infected and being able to 
detect the presence of disease. During this "window of time", the donor may feel normal, all tests on the donor are negative, but the 
donor is a "silent carrier" of the virus. 
The safest blood you can receive is your own (called Autologous Donation). For this and other alternatives, ask your doctor. 
Blood Transfusion Procedure 
Before You will be asked to sign a consent form. Then an intravenous (IV) will be started. A large needle is used because it 
allows the blood to infuse smoothly and prevents damage to the blood cells. 
During You will be watched closely. Your temperature, pulse, blood pressure and IV site will be checked at the start of your blood 
transfusion as well as during the process. 
Many safety measures are taken to be sure you receive the right blood unit. The numbers on your name bracelet will be 
checked to be sure they match the numbers on the blood unit. 
PLEASE NOTE! Inform your nurse if at any time during the transfusion you have any of the following symptoms: 
• Fever • Headache • Itching 
• Chills/shaking • Back or chest pain • Tingling in your fingers 
• Upset stomach/vomiting • Trouble breathing • Muscle cramps 
After: When your blood transfusion is complete, your doctor may order a lab test to see if the blood has helped you. You may ?r 
may not have the IV removed at this time. You also will have your blood pressure, pulse and temperature checked at thrs 
time. 
MRD-31 Rev. 5/99 
(Reverse Side in Spanish) 




Informacion para el Paciente sobre Transfusion de· Sangre 
QueEs 
( 
Una transfusion es un tratamineto donde una persona recibe sangre o una parte de Ia sangre del cuerpo de un donante. Un 
donante es una persona que da su sangre para ayudar a otra persona que lo necesite. Una persona puede recibir sangre por 
cualquiera de las siguientes razones: 
• Pimlida de sangre durante cirugia 
• Problemas de coagulacion sanguinea 
• Shock 
• Enfermedad que no permite que su 
cuerpo produzca celulas sanguineas 
• Heridas 
Cuando Ia sangre se adquiere de un donante es sangre entera. La sangre entera se puede separar en partes que pueden ser 
usadas para el tratamiento de problemas sanguineos. Estas partes o compuestos pueden ser las celulas rojas (RBC), plasma, 
plaquetas o crioprecipitantes. 
Tipos de Sangre 
El grupo mas importante es ABO, que esta dividido en cuatro tipos: 0, A, 8 y AB. Cada persona nace con uno de estos tipos de 
sangre. El factor Rh es algo que todo el mundo tiene en su sangre. Su sangre puede ser Rh positive(+) o negative(-). Ambas 
cosas el tipo de sangre y el factor Rh son necesarios para conseguir un donante compatible con su sangre. 
Seguridad de Ia Sangre 
No hay ninguna garantia que Ia sangre es 100% libre de riesgo. Antes de recibir sangre donada, se probara su sangre para 
asegurar que sea compatible con Ia del donante. Aunque se toman estas medidas, es necesario que tenga en mente que un grupo 
pequeiio de pacientes pueden tener reacciones a Ia sangre donada. Estes sintomas pueden incluir escalofrios, problemr 
respiratorios, alergias en Ia piel, picor y dolor de espalda. Usted sera mantenido bajo observaci6n y se le atendera si desa1'111. 
alguna reaccion. 
Hay una pequeiia posibilidad de que se le transmita alguna enfermad, pueden ocurrir problemas en el proceso de preparar y 
administrar Ia sangre. Las enfermedades mas serias que pueden ser transmitidas a traves de Ia sangre son enfermedades virales 
tales como Ia Hepatitis B, Hepatitis C, HIV(AIDS), Leucemia Humana Tipo T y citomegalovirus. Se han reportado cases de sifilis, 
malaria y Hepatitis A. En estos casos, Ia persona que dona Ia sangre padece Ia enfermedad en el momenta de Ia donaci6n. Por 
favor recuerde que se hace el mayor esfuerzo posible para reducir los riesgos. Estos esfuerzos incluyen: evaluacion cuidadosa de 
los donantes a traves de su historial medico y se hacen pruebas para diagnosticar enfermedades especificas. Si se detecta Ia 
presencia de alguna de estas enfermedades, no se usa esta sangre. 
La detecci6n de enfermedades virales noes siempre 100%. Una razon es el tiempo necesario para una persona infectarse y el 
memento de detectar Ia enfermedad. Durante este tiempo el donante puede sentirse normal, todos los resultados son negativos 
pero el donante puede ser el transmisor silencioso del virus. 
La sangre mas segura que usted puede recibir es Ia suya (donaci6n autologa). Para esta altemativa, consulte con su medico. 
Procedimiento 
Antes: Se le pedira que firme una forma de autorizacion. Se le comenzara una linea intravenosa (IV). Se usara una aguja 
grande para que Ia sangre fluya con suavidad y para prevenir daiios a las celulas sanguineas. 
Durante: Sera observado cuidadosamente. Su temperatura, pulse, presion sanguinea y localizaci6n del IV se revisaran al 
comenzar Ia transfusion y durante el proceso. 
Se usan medidas de seguridad para asegurar que reciba Ia unidad de sangre correcta. Los numeros en el brazalete con 
su nombre se verificaran para asegurar que sean los mismos en Ia unidad de sangre. 
TOME NOTAl Notifique a Ia enfermera si durante Ia transfusion usted ha tenido alguno de estos sintomas: 
• Fiebre • ·Dolor de cabeza • Picor 
( 
• Escalofrios • Dolor de espalda o del pecho • Calambre en los dedos, manes 
• Est6mago descompuesto/vomitos • Problemas respiratorios • Calambre en los dedos o musculares 
Despues: Cuando Ia transfusion este completa su medico ordenara una prueba de laboratorio para ver si Ia sangre le ha ayudado. 
Puede o no que le remuevan eiiV. Se le tomara el pulso, Ia presion sanguinea y Ia temperatura. 











FOR TRANSFUSION OF BLOOD 
AND/OR BLOOD PRODUCTS 
0 0 0 Page29 
1. I have been informed by Dr. that circumstanc1 
may arise during inpatient/outpatient treatment at Lehigh Valley Health Network that may make it necessary 
administer blood and/or blood products to me. I have reviewed the "Patient Information Sheet for Blood Transfusio 
information. 
2. The risks and adverse consequences of accepting blood and/or blood product transfusions as well as the risks ar 
consequences of refusing to accept blood and/or blood product transfusions have been explained to me. 
3. I understand that there are no warranties of any kind, express or implied, of merchantability, fitness, quality 1 
otherwise made in connection with the transfusion of blood and/or blood products. 
4. I acknowledge that I have been given an opportunity to ask any questions that I might have concerning the risks 1 
I hereby consent to permitting authorized members of the hospital staff to administer blood and/or blood products and sue 
additional transfusions as may be deemed advisable by my doctor. 
Witness to Signature 
Second Witness to Signature (two witnesses are required if Patient 
signs by making a mark "X'1 
Signature of Patient 
If Patient is a minor or is incapable of consenting, signature of nearest 





1 have discussed the procedure as outlined above with the patient or the patient's authorized representative and answerec 
all questions. 
Signature of Attending Physician Date 




PAGE 3 - SIDE 1 OF :i 
REFUSAL 
FOR TRANSFUSION OF BLOOD 
AND/OR BLOOD PRODUCTS 
Page 30 
( 
I, , refuse to consent to the transfusion of 
blood and/or blood products. I acknowledge that I have been informed and fully understand the risks and dangers, which 
may or can result from this refusal. I further understand that this refusal will probably result in adverse consequences 
including death. ' 
I release the physicians, Lehigh Valley Health Network, its employees, agents and representatives from any and all 
liability which could occur as a result of this refusal. 
Witness to Signature 
Second Witness to Signature (two witnesses are required if Patient 
signs by making a mark "X'1 
Signature of Patient 
If Patient is a minor or is incapable of consenting, signature of nearest 






PHYSICIAN'S CERTIFICATION: I have discussed the information outlined above with the Patient/Authorized Person and 
answered all his/her questions. Following our discussion, the Patient/Authorized Person signed this Form in my 
presence. It is my opinion that the Patient/Authorized Person understood all of the matters discussed on this date. 
Signature of Attending Physician Date 
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HEALTH NETWORK LABORATORIES Page 31 
( CRITICAL I CALLBACK LIMITS 
AFB Smear Any Positive 
Ammonia > 100 umoi/L 
Amylase > 300 U/L 
Bilirubin > 15.0 mg/dL 
Call all outpatient 
neonate bilirubins, 
(NBIL) 
Blood Culture Any Positive 
Calcium < 6.5 > 12.0 mg/dL 
i-Calc < 3.3 > 6.5 
Chloride < 75 > 125 mEq/L 
C02 content < 15 >40 mEq/L 
( Creatinine > 5.0 mg/dL 
CSF Protein > 75 mg/dL 
CSF Glucose <40 >400 mg/dL 
CSF Gram Stain Any Positive 
Drugs, Therapeutic Above Therapeutic Digoxin, >2.0 
Range Dilahtin, >20.0 
(In Chemistry) Theophylline, >20.0 
Lithium, >1.2 
Fibrinogen <75 > 750 mg/dL 
Gentamicin Trough> 2.0 ug/mL 
Peak > 12.0 
Glucose <40 >400 newborn< 30, mg/dL 
Hematocrit < 25 >55 neonate <27 >75,% 
Hemoglobin < 8.0 > 20.0 neonate <9.0, >25.0 
g/dL 
( Lactate >4.0 mmoi/L 
Magnesium < 1.0 > 5.0 mg/dL 
Osmolality <250 > 325 mOs/kg 
HEALTH NETWORK LABORATORIES 



















Revised: June 2, 1999 
< 60 
< 20 > 60 
< 7.20 > 7.55 
> 20 
< 2.0 > 7.0 
<50 > 750 
(1st time only) 
< 3.0 > 6.0 
> 30.0 
> 100.0 
< 120 > 155 
> 13.0 
Trough> 2.0 
Peak > 12.0 
> 2.0 




ANC < 1.5 > 20.0 


























June 17, 1999 
Dear Physician Practice Healthcare Provider, 
Cedar Crest & l-i8 Page 3 
Post Office Box 689 
Allentown, Pennsylvania 18105-1 ;)6 
I wanted to make you aware of a new program, which is coming to the Lehigh 
Valley. Lehigh Valley Hospital and Health Network is bringing The Chronic 
Disease Self-Management Program to the Lehigh Valley for community 
members who live with chronic conditions. This is the only program of its kind on 
the region. 
The program is a course given two and a half hours, once a week, for seven 
weeks, in community settings such as senior centers, churches, libraries and 
hospitals. People with different chronic health problems attend the course 
together. Courses are facilitated by two trained leaders, one or both of whom are 
non-health professionals with a chronic disease themselves. 
Subjects covered include: 1) techniques to deal with problems such as 
frustration, fatigue, pain and isolation, 2) appropriate exercise for maintaining and 
improving strength, flexibility, and endurance, 3) appropriate use of medications, 
4) communicating effectively with family, friends, and health professionals, 5) 
nutrition, and, 6) use of community resources. Each participant in the course 
receives a copy of the companion book, Living A Healthy Life With Chronic 
Conditions, and an audio relaxation tape, Time for Healing. 
The Self-Management Course will not conflict with existing programs or 
treatment. It is designed to enhance regular treatment and disease -specific 
education such as Better Breathers, cardiac rehabilitation, or diabetes instruction. 
In addition, many people have more than one chronic condition. The program is 
especially helpful for these people, as it gives them the skills to coordinate all 
things needed to manage their health, as well as to help them keep active in their 
lives. 
I am in search of volunteer non-professional persons who are successfully 
managing a chronic condition and are interested in participating in the program 
as a facilitator. If you are aware of any persons who fit this description, please 
refer them to me and I will arrange for them to attend the trainer class. It is 
expected the trainer class will be held in September with the first course for 
participants to follow. 
Please look for more information regarding the first course in the near future. 
There will be a cost to the participant for attending the course. I am investigating 
reimbursement for this cost from insurance carriers. I have included a summary 
sheet with additional information about the Chronic Disease Self-Management 
Course. If you have further questions, please do not hesitate to contact me at 
610-402-5015, or email Wendy.Robb@LVH.com. 
I look forward to this exciting and unique opportunity to assist our community 
members with chronic conditions. Thank you for your time and consideration. 
Sincerely, 
v~~· 
Wendy J. Robb, RN, MSN, 









Chronic Disease Self-Management 
Program 
The Chronic Disease Self-Management Program is a course given two and a half 
hours, once a week, for seven weeks, in community settings such as senior 
centers, churches, libraries and hospitals. People with different chronic health 
problems attend the course together. Courses are facilitated by two trained 
leaders, one or both of whom are non-health professionals with a chronic disease 
themselves. 
Subjects covered include: 
~ Techniques to deal with problems such as frustration, fatigue, pain and 
isolation 
~ Appropriate exercise for maintaining and improving strength, flexibility, 
and endurance 
~ Appropriate use of medications 
~ Communicating effectively with family, friends, and health 
professionals 
~ Nutrition 
~ Use of community resources 
Each participant in the course receives a copy of the companion book, Living A 
Healthy Life With Chronic Conditions, and an audio relaxation tape, Time for 
Healing. 
The Self-Management Course will not conflict with existing programs or 
treatment. It is designed to enhance regular treatment and disease-specific 
education such as Better Breathers, cardiac rehabilitation, or diabetes instruction. 
In addition, many people have more than one chronic condition. The program is 
especially helpful for these people, as it gives them the skills to coordinate all 
things needed to manage their health, as well as to help them keep active in their 
lives. 
How was the Program developed? 
The Division of Family and Community Medicine in the School of Medicine at 
Stanford University received a five year research grant from the federal Agency 
for Health Care Research and Policy and the State of California Tobacco Related 
Diseases Office. The purpose of the research was to develop and evaluate, 
through a randomized controlled trial, a community-based self-management 




The research project had several investigators: Halsted Holman, MD, Stanford 
Professor of Medicine; Kate Lorig, DrPH, Stanford Associate Professor of ( 
Medicine; David Sobel, MD, Regional Director of Patient Education for the 
Northern California Kaiser Permanente Medical Care Program; Albert Bandura, 
PhD, Stanford Professor of Psychology; and Byron Brown, Jr, PhD, Stanford 
Professor of Health Research and Policy. The Program was written by Dr. Lorig, 
Virginia Gonzalez, MPH, and Diana Laurent, MPH, all of the Stanford Patient 
Education Research Center. Ms. Gonzalez and Ms. Laurent also served as 
integral members of the research team. 
The process of the course was based on the experience of the investigators and 
others with self-efficacy, the confidence that one has that he or she can master a 
new skill or affect one's own health. The content of the course was the result of 
focus groups with people with chronic disease, in which the participants 
discussed which content areas were the most important for them. 
How was the Program evaluated? 
Over 1 ,200 people with heart disease, lung disease, stroke, or arthritis 
participated in a randomized, controlled test of the Program, and were followed 
for up to three years. Researchers looked for changes in many areas: health 
status (disability, social/role limitations, pain and physical discomfort, 
energy/fatigue, shortness of breath, psychological well-being/distress, 
depression, health distress, self-rated general health), health care utilization 
(visits to physicians, visits to emergency department, hospital stays, and nights in ( 
hospital), self-efficacy (confidence to perform self-management behaviors, 
confidence to manage disease in general, confidence to achieve outcomes), and 
self-management behaviors (exercise, cognitive symptom management, mental 
stress management/relaxation, use of community resources, communication with 
physician, and advance directives). 
What were the results? 
Subjects who took the Program, when compared t those who did not, 
demonstrated significant improvements in exercise, cognitive symptom 
management, communication with physicians, self-reported general health, 
health distress, fatigue, disability, and social/role activities limitations. They also 
spent fewer days in the hospital, and there was also a trend toward fewer 
outpatient visits and hospitalizations. These data yield a cost to savings ratio of 
approximately 1 0:1. Many of these results persist for as long as three years. 
For more information related to outcomes, please refer to the following article: Lorig, KR, et al. (1999). Evidence 
Suggesting That a Chronic Disease Self-Management program Can Improve health Status While Reducing 
Hospitalization: A Randomized Trial, Medical Care, 37(1), 5-14. 
For additional information, please contact Wendy Robb, Chronic 
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1999-2000 
(Approved by LVH Board of Trustees - 6/2/99 
and MHC Board of Trustees - 6/8/99) 
David M. Caccese, MD 
Edward M. Mullin, Jr., MD 
Robert X. Murphy, Jr., MD 
John J. Shane, MD 
John J. Shane, MD 




7/1/99 - 6/30/2000 
7/1199 - 6/30/2000 
Alphonse A. Maffeo, MD, Chairperson 
Domenico Falcone, MD, Vice Chairperson (MHC) 
Karen A. Bretz, MD, Vice Chairperson for Quality Assurance 
Thomas M. McLoughlin, Jr., MD, Vice Chairperson for Education and Research 
Division of Cardiac Anesthesia 
Division of Pain Management 
Department of Dentistry 
Eric J. Marsh, DMD, Chairperson 
Thomas M. McLoughlin, Jr., MD, Chief 
Bruce D. Nicholson, MD, Chief 
S. Clark Woodruff, DMD, Vice Chairperson (MHC) 
Scott A. Gradwell, DMD, Vice Chairperson (LVH) 
Charles J. Incalcaterra, DMD, Residency Program Director (LVH) 
Russ S. Bergman, DMD, Residency Program Director (MHC) 
Dominic P. Lu, DDS, Director of Dental Externship Education 
Division of Endodontics 
Division of General Dentistry 
Division of Orthodontics 
Division of Pediatric Dentistry 
Division of Periodontics 
Division of Prosthodontics 
Division of Special Care 
Mark R. Eisner, DMD, Chief 
Charles A. Kosteva, DDS, Chief (LVH) 
Gary G. Peters, DDS, Chief (MHC) 
Sara C. Karabasz, DMD, Chief 
Marsha A. Gordon, DDS, Chief 
Scott A. Gradwell, DMD, Chief (LVH) 
Ann K. Astolfi, DMD, Chief (MHC) 
John D. Karabasz, DMD, Chief (LVH) 
Bernard D. Servagno, DMD, Chief (MHC) 
Russel S. Bleiler, DDS, Chief 
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Medical Staff Department Chairpersons and Chiefs of Divisions and Sections - 1999/2000 
Department of Emergency Medicine 
Michael S. Weinstock, MD, Chairperson 
RichardS. MacKenzie, MD, Vice Chairperson 
Brian A. Nester, DO, Associate Vice Chair (MHC) 
Alexander M. Rosenau, DO, Associate Vice Chair/Practice Management 
Charles C. Worrilow, MD, Director, Education 
Michael B. Heller, MD, Residency Program Director 
Division of Emergency Medicine 
Division of Prehospital Emergency 
Medical Services 
Department of Family Practice 
William L. Miller, MD, Chairperson 
Julie A. Dostal, MD, Vice Chairperson (LVH) 
MichaelS. Weinstock, MD, Chief 
. John F. McCarthy, DO, Chief 
Dale M. Weisman, MD, Vice Chairperson (MHC) 
William L. Miller, MD, Residency Program Director 
Karla N. Noel, MD, Chief Resident 
Division of Occupational Medicine 
Division of Home Care 
Department of Medicine 
John P. Fitzgibbons, MD, Chairperson 
Carmine J. Pellosie, DO, Chief 
Fred D. Fister, MD, Chief 
Jonathan H. Munves, MD, Vice Chairperson (MHC) 
Richard H. Snyder, MD, Vice Chairperson (LVH) 
Richard H. Snyder, MD, Residency Program Director 
Joseph A. Candio, MD, Chief for Clinical Practice 
Larry N. Merkle, MD, Student Mentor 
Zubina Mawji, MD, Chief Medical Resident 
Division of Allergy 
Division of Cardiology 
Division of Dermatology 
Division of Endocrinology/Metabolism 
Division of Gastroenterology 
Division of General Internal Medicine 
Division of Geriatrics 
Division of Hematology/Medical Oncology 
Division of Infectious Diseases 
Division of Nephrology 
Howard A. Israel, MD, Chief 
D. Lynn Morris, MD, Chief 
Norman H. Marcus, MD, Associate Chief (LVH) 
Robert H. Biggs, DO, Associate Chief (MHC) 
Arthur C. Sosis, MD, Chief 
Larry N. Merkle, MD, Chief 
Mohammad I. Arastu, MD, Associate Chief (MHC) 
Carl F. D'Angelo, MD, Chief 
Lawrence W. Bardawil, MD, Associate Chief (LVH) 
Frederic A. Stelzer, MD, Associate Chief (MHC) 
Keith R. Doram, MD, Chief 
Jonathan H. Munves, MD, Associate Chief (MHC) 
Francis A. Salerno, MD, Chief 
David P. Carney, MD, Associate Chief 
Gregory R. Harper, MD, PhD, Chief 
Luther V. Rhodes III, MD, Chief 
Jeffrey A. Jahre, MD, Associate Chief (MHC) 
Joseph C. Guzzo, MD, Chief 
Nelson P. Kopyt, DO, Associate Chief 






Medical Staff Department Chairpersons and Chiefs of Divisions and Sections- 1999/2000 
Department of Medicine (cont.) 
Division of Neurology 
Division of Physical Medicine & Rehabilitation 
Division of Pulmonary 
Division of Rheumatology 
Alexander D. Rae-Grant, MD, Chief 
Pradip K. Toshniwal, MD, Associate Chief (MHC) 
Jane Dorval, MD, Chief 
Jay H. Kaufman, MD, Chief 
Brian Burlew, MD, Associate Chief (MHC) 
Albert D. Abrams, MD, Chief 
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Ellen M. Field-Munves, MD, Associate Chief (MHC) 
Department of Obstetrics and Gynecology 
Stephen K. Klasko, MD, Chairperson 
Ernest Y. Normington, MD, Vice Chairperson 
Vincent Lucente, MD, Vice Chairperson 
Stephen K. Klasko, MD, Residency Program Director 
Craig J. Sobolewski, MD, Assistant Residency Program Director 
Division of Obstetrics 
Section of Maternal-Fetal Medicine 
Section of Clinical Obstetrics 
Division of Gynecology 
Section of Synecologic Oncology 
Section of Pelvic Reconstructive Surgery 
Section of Reproductive 
Endocrinology & Infertility 
Division of Primary 08/SYN 
Department of Pathology 
John J. Shane, MD, Chairperson 
William B. Dupree, MD, Vice Chairperson 
Division of Clinical & Anatomic 
Division of Dermatopathology 
Division of Forensic 
Division of Synecologic Pathology 
Division of Neurosciences 
Department of Pediatrics 
John D. VanBrakle, MD, Chairperson 
Dennis W. Kean, MD, Vice Chairperson 
Division of Allergy 
Division of Behavioral Pediatrics 
Division of Cardiology 
Division of Development & Rehabilitation 
Division of General Pediatrics 
Division of Neonatology 
Division of Neurology 
Division of Pulmonary 
James Balducci, MD, Chief 
James Balducci, MD, Chief 
Orion A. Rust, MD, Chief 
Vincent R. Lucente, MD, Chief 
Weldon E. Chafe, MD, Chief 
Vincent R. Lucente, MD, Chief 
Albert J. Peters, DO, Chief 
Gregory J. Radio, MD, Chief 
John J. Shane, MD, Chief (LVH) 
Dion T. Manhoff, MD, Chief (MHC) 
Howard B. Altman, MD, Chief 
Isidore Mihalakis, MD, Chief 
William B. Dupree, MD, Chief 
(Vacant) 
(Vacant) 
Sarah J. Fernsler, MD, Chief 
Louis W. Hansrote, MD, Chief 
Karen E. Senft, MD, Chief 
Oscar A. Morffi, MD, Chief 
Ian M. Gertner, MD, Chief 
Martha A. Lusser, MD, Chief 
Robert W. Miller, MD, Chief 
Medical Staff Department Chairpersons and Chiefs of Divisions and Sections - 1999/2000 
Department of Psychiatry 
Michael W. Kaufmann, MD, Chairperson 
Susan D. Wiley, MD, Vice Chairperson (LVH) 
David L. Schwendeman, MD, Vice Chairperson (MHC) 
Division of Adolescent Inpatient Psychiatry 
Division of Adult Inpatient Psychiatry 
Division of Consultation/Liaison Psychiatry 
Division of Psychiatric Ambulatory Care 
Division of Psychiatric Home Care 
Department of Radiation Oncology 
Victor R. Risch, MD, PhD, Chairperson 
Charles F. Andrews, MD, Vice Chairperson 
John F. Campion, MD, Chief 
Clifford H. Schilke, MD, Co-Chief 
Laurence P. Karper, MD, Co-Chief 
Joseph L. Antonowicz, MD, Chief 
Susan D. Wiley, MD, Chief (LVH) 
Joel Lerman, MD, Chief (MHC) 
Michael W. Kaufmann, MD, Chief 
Department of Radiology/Diagnostic Medical Imaging 
Robert Kricun, MD, Chairperson 
Elliot I. Shoemaker, MD, Vice Chairperson (LVH) 
Hal L. Folander, MD, Vice Chairperson (MHC) 
John F. Cox, MD, Residency/Fellowship Program Director 
Division of Diagnostic Radiology 
Section of Chest 
Section of Gastrointestinal 
Section of Genitourinary 
Section of Orthopedics 
Section of Cardiovascular/Interventional 
Section of Trauma/Emergency Medicine 
Section of Pediatrics 
Section of Neuroradiology 
Section of Mammography 
Division of Nuclear Medicine 
Department of Surgery 
Herbert C. Hoover, Jr., MD, Chairperson 
Alan H. Wolson, MD, Chief 
Alan H. Wolson, MD, Chief 
Christopher L. Brown, MD, Chief 
Christopher L. Brown, MD, Chief 
John F. Cox, MD, Chief 
James W. Jaffe, MD, Chief 
Hal L. Folander, MD, Associate Chief (MHC) 
James A. Newcomb, MD, Chief 
Howard D. Rosenberg, MD, Co-Chief 
Thomas R. Fitzsimmons, MD, Co-Chief 
Elliot I. Shoemaker, MD, Chief 
John G. Pearce, MD, Chief 
Diane Garrigan, DO, Associate Chief (MHC) 
Robert J. Rienzo, MD, Chief 
Gregg D. Schubach, MD, Associate Chief (MHC) 
Michael D. Pasquale, MD, Vice Chairperson for Clinical Affairs (LVH) 
Gregory Brusko, DO, Vice Chairperson (MHC) 
Mark C. Lester, MD, Vice Chairperson for Operations (Operating Room and OI) 
Gary G. Nicholas, MD, Vice Chairperson of Educational Affairs 
Walter :r. Okunski, MD, Senior Advisor to the Chair 
Gary G. Nicholas, MD, General Surgery Residency Program Director/Education Director 
Robert D. Riether, MD, Colon/Rectal Residency Program Director 







Medical Staff Department Chairpersons and Chiefs of Divisions and Sections - 1999/2000 
Department of Surgery (cont.) 
Michael D. Pasquale, MD, Surgical Critical Care Residency Program Director 
Scott W. Beman, MD, Chief Surgical Resident 
Michael T. Kennedy, MD, Chief Surgical Resident 
Rovinder S. Sandhu, MD, Chief Surgical Resident 
Division of Cardio-thoracic Surgery 
Division of Colon/Rectal Surgery 
Division of General Surgery 
Section of Pediatric Surgery 
Section of Transplantation Surgery 
Division of Hand SUrgery 
Division of Neurological Surgery 
Section of Neuro Trauma 
Division of Ophthalmology 
Division of Oral/Maxillofacial Surgery 
Division of Orthopedic Surgery 
Section of Foot and Ankle Surgery 
Section of Ortho Trauma 
Division of Otolaryngology 
Division of Plastic/Reconstructive Surgery 
Division of Trauma-Surgical Critical Care 
Section of Burn 
Section of Pediatric Trauma 
Section of Trauma Research 
Division of Urology 
Division of Vascular Surgery 
x:\wordwin\cred\chiefs\2000jazzedchiefs 
Michael C. Sinclair, MD, Acting Chief 
John J. Stasik, MD, Chief 
Lester Rosen, MD, Associate Chief 
Gerald P. Sherwin, MD, Chief 
Douglas R. Trostle, MD, Associate Chief (LVH) 
Gregory Brusko, DO, Associate Chief (MHC) 
Chris CN. Chang, MD, Chief 
Craig R. Reckard, MD, Chief 
Michael A. Chernofsky, MD, Chief 
Mark C. Lester, MD, Chief 
Robert P. Marcincin, MD, Associate Chief (MHC) 
(Vacant) 
Glen L. Oliver, MD, Chief 
Alan B. Leahey, MD, Associate Chief (LVH) 
Steven J. Kanoff, MD, Associate Chief (MHC) 
Mark H. Grim, DMD, Chief 
Jonathan A. Tenzer, DMD, Associate Chief (MHC) 
Peter A. Keblish, Jr., MD, Chief 
George A. Arangio, MD, Associate Chief (LVH) 
Ranjan Sachdev, MD, Associate Chief (MHC) 
Chief (Vacant) 
David P. Steed, DPM, Associate Chief 
Patrick B. Respet, MD, Chief 
John D. Harwick, MD, Chief 
John S. Papola, MD, Associate Chief 
Walter J. Okunski, MD, Chief 
Geoffrey G. Hallock, MD, Associate Chief (LVH) 
Manny Iyer, MD, Associate Chief (MHC) 
Michael D. Pasquale, MD, Chief 
Mark D. Cipolle, MD, PhD, Associate Chief 
Kevin J. Farrell, MD, Chief 
Walter J. Okunski, MD, Associate Chief 
James G. Cushman, MD, Chief 
Mark D. Cipolle, MD, PhD, Chief 
Edward M. Mullin, Jr., MD, Chief 
Richard M. Lieberman, MD, Associate Chief 
Gary G. Nicholas, MD, Chief 
James G. Goodreau, MD, Associate Chief (LVH) 







Medical Directors of Patient Care Units, 
Laboratories and Programs 
1999-2000 
Cedar Crest & I-78 
(Approved by LVH Board of Trustees - 6/2/99 
and MHC Board of Trustees - 6/8/99) 
Medical Critical Care Director - Richard H. Snyder, MD 
Surgical Critical Care Director - Michael D. Pasquale, MD 




Medical Intensive Care Unit 
- Bryan W. Kluck, [)0 
- Walter J. Okunski, MD/Kevin J. Farrell, MD 
-James E. Kintzel, MD 
- D. Lynn Morris, MD 
-JayS. Cowen, MD 
( 
-Stephen C. Matchett, MD {Associate Medical Director) 
Open Heart Unit 
Operating Room 
Progressive Coronary Care Unit 
Post Anesthesia Care Unit 
Special Care Unit 
Surgical Intensive Care Unit 
Transitional Open Heart Unit 
Transitional Trauma Unit 










- Theodore G. Phillips, MD 
-Mark C. Lester, MD/Thomas M. McLoughlin, Jr., MD 
-Bryan W. Kluck, [)0 
-Karen A. Bretz, MD 
- Stephen C. Matchett, MD 
-Mark D. Cipolle, MD, PhD ( 
- Theodore G. Phillips, MD 
-Kevin E. Glancy, MD 
-Michael D. Pasquale, MD/Mark C. Lester, MD 
-Bruce A. Feldman, [)0/J. Harry Pickle IV, MD 
- L. Kyle Walker, MD 
- Gary G. Nicholas, MD 
-Gerald P. Sherwin, MD/Brian P. Murphy, MD 
-Peter A. Keblish, Jr., MD 
-Stephen R. Shore, MD/Mark C. Lester, MD 
-Gregory R. Harper, MD, Ph[)/[)avid M. Caccese, MD 
- Drew S. Harrison, MD 





Medical Directors of Patient Care Units, Laboratories and Programs- 1999/2000 
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17th & Chew 
Ambulatory Surgery Unit 
Labor & Delivery Room 
Mother/Baby 
Neonatal Intensive Care Unit 
Pediatric Ambulatory Surgery Unit 
High Risk Perinatal Unit 
Perinatal Center 
Post Anesthesia Care Unit 






Behavioral Health Emergency Services 
Muhlenberg Hospital Center 
3S/4S 
Operating Room/ Ambulatory Surgical Unit 
Post Anesthesia Care Unit 
Psychiatry 
Respiratory 
Short Procedure Unit 
Off-Site Programs 
Adolescent Partial Hospitalization Program 
Adult Partial Hospitalization Program 
Guidance Program 
Transitional Living Center 
- J. John Collins, MD/Walter J. Okunski, MD 
- Orion A. Rust, MD 
- Orion A. Rust, MD/Ian M. Gertner, MD 
- Ian M. Gertner, MD 
-John D; Harwick, MD 
- James Balducci, MD 
- Robert 0. Atlas, MD 
- Karen A. Bretz, MD/J. John Collins, MD 
- David P. Carney, MD 
-Steven A. Scott, MD (Associate Medical Director) 
- Vincent R. Lucente, MD 
-John F. Campion, MD 
- Clifford H. Schilke, MD 
-Laurence P. Karper, MD 
-Laurence P. Karper, MD 
-Jonathan H. Munves, MD 
- Gregory Brusko, DO 
- Domenico Falcone, MD 
- David L. Schwendeman, MD 
-Douglas F. Turtzo, MD 
- Anthony D. Dippolito, MD 
-James G. Showalter, MD 
- Ralph A. Primelo, MD 
-Susan D. Wiley, MD 
- Susan D. Wiley, MD 
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LABORATORY AND OTHER SERVICE MEDICAL DIRECTORS 
John & DorDthy Morgan CtUICer Center 
Director 
Associate Director, Research 
Associate Director, Education 
Associate Director, Cancer Control 
Director, Breast Health Services 
Associate Director, Breast Health Services 
Director, Breast Imaging 
HospitDI Ltzb/Service Directors 
Cardiac Catheterization Lab (Invasive Cardiology) 
Center for Women's Medicine Perinatal Testing 
Endocrine Testing Station 
GI Labs 
Helwig Diabetes Center 
MedEvac/Emergency Med Institute 
Metabolic Bone Program 
NeuroDiagnostic Lab 




Sleep Disorders Lab 
Vascular Lab 





Transfusion Medicine & HLA Lab 
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( 
- Gregory R. Harper, MD, PhD 
-Herbert C. Hoover, Jr., MD 
-Victor R. Risch, MD, PhD 
- Mark J. Young, MD 
-Gregory R. Harper, MD, PhD 
-John G. Pearce, MD 
- John G. Pearce, MD 
- D. Lynn Morris, MD 
- Vincent R. Lucente, MD 
- Dean F. Dimick, MD 
-Carl F. D'Angelo, MD 
-Robert D. Riether, MD (Associate Medical Director) 
- Larry N. Merkle, MD 
-John F. McCarthy, DO 
- Donald E. Barilla, MD 
- Alexander D. Rae-Grant, MD ( 
- Kimberly C. Brown, MD 
- Karen A. Bretz, MD 
-John P. Galgon, MD 
-Jonathan Hertz, MD 
- John P. Galgon, MD 
- William Gee, MD 
-Gary G. Nicholas, MD (Assoc. Medical Director- LVH) 
-James D. Balshi, MD (Assoc. Medical Director- MHC) 
- John J. Shane, MD 
-David Beckwith, PhD (Director) 
-William B. Dupree, MD 
-Howard B. Altman, MD 





GUIDELINES FOR CONSULTATIONS 
Physicians are professionals, and as professionals, expect and deserve a certain amount of 
respect from their physician colleagues. We have had some discussions about the process 
of requesting and performing consultations at this hospital, and how this process might be 
improved. 
The following suggestions are offered as "guidelines" both for physicians requesting 
consultations, and for physicians performing consultations. Much of what follows has been 
previously suggested by Dr. John Van.Brakle and is not original with me. Also, much of 
what follows is simply a reflection of the type of professional behavior which I believe all 
of us learned at one time, but are now often too busy to follow. In addition, I believe that if 
the "guidelines" were followed we would significantly improve professional and patient 
communication, improve the quality of patient care, and reduce the cost of the care which 
we deliver to our patients. 
Remember, the request for a consultation from the attending physician to another physician 
or health care professional is a request for an opinion regarding a specific issue related to the 
patient's diagnosis or care. 
• The consultation request should address a specific question or a specific need. e.g . 
"Please help diagnose my patient's problem", "Please recommend the best treatment 
for my patient's condition", "Please evaluate my patient medically before a planned 
operation", or "Please see my patient for possible abdominal aortic aneurysm repair", 
etc. 
• A personal call to the consultant from the attending physician stating the reason for 
the consultation request, what is expected from the consultant, and whether orders 
should be written by the consultant is appropriate, encouraged, and a simple 
professional courtesy. The attending/referring physician may lmow or have 
information about the patient which is not available in the medical record which 
would be helpful for the consultant to lmow. 
• It should be clear in the consultation request whether the attending physician is 
requesting the consultant's advice, opinion, or direct involvement in the patient's care. 
• "Courtesy Consultations" are appropriate and should be placed to physicians who 
have been closely involved with the patient's care, but whose opinion is not 
necessarily needed or required by the attending physician. An example would be a 
"courtesy consultation" to the patient's family physician by the attending surgeon 
who is preparing the patient for an uncomplicated mastectomy. A patient charge 
should not be generated for a "courtesy consultation". 
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• "Teaching Consultations" are also appropriate for the benefit of residents in training 
and medical students when an interesting or unusual patient problem becomes 
apparent to the attending physician, but the services of another physician are not 
necessarily required. Patients should be informed that their problem is unusual or 
interesting and asked if it would be acceptable to have another physician and some 
resident physicians stop by to review the patient's record and briefly interview and 
examine the patient. A patient charge should not be generated for a "teaching 
consultation". This type of consultation is in the best interest of the goals of a 
teaching institution, its medical staff, resident physicians, and students. 
• It should be made clear at the time of the request for the consultation whether the 
attending physician wants the consultant to discuss his/her findings and 
recommendations with the patient and the patient's family or whether the 
recommendations should be discussed with the attending physician either solely or 
primarily. 
( 
• The consultant should always introduce him/herself to the patient and his family if 
they are present. He/she should inform the patient and family that he has come to see 
the patient at the request of the attending physician and should mention the referring 
physician by name. He/she should specify why he was asked to see the patient by the 
referring physician. It is also helpful to ask the name of the patient's primary care 
physician. After the evaluation the consultant should tell the patient that he will ( 
discuss his findings and recommendations with the patient's attending physician and 
that together they will develop a plan for the patient's future care. 
• It is useful for the consultant to provide his professional card or to provide his name 
in writing to the patient and his/her family. 
• After the consultation is performed, a personal call from the consultant to the 
attending physician detailing the findings, recommendations, and suggestions 
regarding the further involvement of the consultant in the patient's care is appropriate 
as a professional courtesy and in the interests of the highest quality patient care. The 
initial question asked by the attending physician should be answered by the consultant 
at this time. 
• At this point, it should be clarified as to whether the attending physician wants to 
write all of the orders in the patient's chart or whether the consultant has the authority 
to write orders for diagnostic tests and treatments. 
• The consultant should not write an order for another consultant to see the patient 
without discussing this with the attending physician. The consultant should not order 
an invasive diagnostic or therapeutic procedure for a patient without first discussing ( 









by the attending physician. You are offering an opinion which the attending 
physician may or may not choose to follow. 
As a consultant, discuss the need for post discharge follow up of the patient with the 
attending physician. 
If the consultation request is for "patient management" and the consultant feels that 
the extent of his/her involvement would be best served by a transfer from the referring 
physician to the consultant's service, this should be discussed with the attending 
physician after the patient is seen and evaluated. 
The consultation report should be completed before the consultant leaves the patient 
care unit. This note should answer the question which was originally addressed in the 
consultation. The note may be brief, but should be followed by a longer more 
detailed note, preferably one which is dictated and transcribed so that it will become 
a legible part of the patient's permanent medical record. References can be provided 
if useful, but not simply to "show off'. 
It is useful to have a copy of the detailed consultation report mailed to the attending 
physician as well as to the patient's primary care physician. 
As a consultant, never criticize the previous or present treatment to the patient or 
his/her family. 
• As a consultant, if you have strong objections to the patient's present diagnosis or 
treatment, do not start an argument in the medical record. Discuss you opinions with 
the referring physician directly. 
• As an immediate response it is acceptable to say "I don't know, but I will find out" 
or "I need a little time to think and/or talk this over with someone else". This is 
preferable to guessing. If you really don't know -look it up! 
Hopefully by following the above simple guidelines we will improve communication 
between physicians and between physicians and patients. This improvement in 
communication will lead to better professional relationships between physicians and health 
care providers and may significantly reduce the risk of medical malpractice. I believe that 
if these guidelines are followed we also may see a significant reduction in the duplication of 
studies and in the cost of care which we deliver to our patients. 
David M. Caccese, M.D. 






The following awards were presented at the 
1999 Resident Graduation Ceremony held on 
June 11, 1999. 
Clinical Teacher of the Year in Dentistry-
Gregory Dimmich, DMD 
Clinical Teacher of the Year in Obstetrics 
and Gynecology-Michael Sheinberg, MD. 
Clinical Teacher ofthe Year in Colon and 
Rectal Surgery-Robert D. Riether, MD. 
Clinical Teacher of the Year in General 
Surgery-Gerald Sherwin, MD. 
Clinical Teacher of the Year in Internal 
Medicine-Yehia Mishriki, MD. 
Headley White Award for Outstanding 
Teacher in Family Practice-Joanne Cohen-
Katz, Ph.D. 
Diagnostic Radiology Case of the Week 
Award-Randolph Wojcik, MD. 
Obstetrics and Gynecology National Faculty 
Award for Excellence in Resident Education 
(CREOG) Award-Craig Sobolewski, MD. 
Stephen Renner, D.O. Excellence in 
Cardiology Award-Nainesh Patel, MD. and 
Paresh Shah, MD. 
1 
John E. Stahler, M.D. and James C. Rex, 
M.D. Surgery Research Award-Michael 
Morrissey, MD. 
Paul R. Bosanac, M.D. Research Award-
Michael Kennedy, MD. 
Society of Teachers ofFamily Medicine 
Resident Teacher Award-Andrew McLaren, 
M.D. 
Hahnemann University School ofMedicine 
Dean's Special Award for Excellence in 
Clinical Teaching-Brian Stello, MD. 
Penn State College ofMedicine Award for 
Excellence in Clinical Teaching for the 
Department of Obstetrics and Gynecology-
James Balducci, M.D. 
Fred D. Fister, M.D. Family Physician 
Award-Susan Snyder Mathieu, MD. 
News from the Library 
OVID/PubMed TRAINING. 
To schedule one-on-one OVID (MEDLINE) 
training session, call Barbara Iobst in the 
Health Sciences Library at 402-8408. 
Barbara can also instruct you in the use of 
PubMed, a free, Web-based MEDLINE 
service offered by the National Library of 
Medicine (NLM). MEDLINE can be 
searched directly using PubMed. 
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New Publications- Cedar Crest & 1-78 
"Hematology/Oncology Clinics ofNorth 
America" Subject: "Advances in Breast 
Cancer Therapy" Guest Editor: G. Sledge, 
Jr. Volume 13, No. 2, 1999 
"Endovascular Skills: Guidewires, Catheters, 
Arteriography, Balloon Angioplasty, Stents'' 
Author: P. Schneider - Call No. WG 170 
S359e 1998 
"Bates' Guide to Physical Examinationa and 
History Taking," 7th edition Editor: L. 
Bickley, et al. - Call No. WB 205 B583b 
1999 (Reference Book). 
New Publications - 17th And Chew 
"Principles Of Manual Medicine," 2nd 
edition Author: P. Greenman- Call No. 
WB460G814p 
"Maternal-Fetal Medicine " 4th edition , 
Author: R Creasy, et al.- Call No. WQ 211 
M425 1999. 
New Publications - Muhlenberg 
Hospital Center 
"Emergency Medicine: Concepts and Clinical 
Practice," 4th edition. Editor: P. Rosen, et 
al. - Call No. WB 105 ESSS 1998. 
MICBOMEDEX. 
MICROMEDEX, a drug-information 
database, will be provided through the 
Hospital's Intranet in a slightly different 
format in the near future. Details will follow. 
2 
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News from the Office of ( 
Educational Technology 
Computer-Basecl Training (CBD: 
. CBT has replaced instructor-led classes 
previously held at L VH. A proctor will be in 
the room with the learner while s/he takes 
the CBT, but the learner will control the 
pace and objectives of the learning. 
Topics covered by CBT include: 
Access 2.0 & 97, Windows NT 4, Word 97, 
Excel 97, PowerPoint 97, PHAMIS 
Lastword Inquiry only, & E-mail GUI 
CBT takes place. in JDMCC, Suite 401. 
From April through December 1999, there 
will be two CBT sessions every Tuesday. 
The morning session is 8:00 am to noon. 
The afternoon session is 12:30 to 4:30 pm. 
Twelve slots are available for each session. 
To register, please contact Bonnie ( 
Schoenebergervia email or at 402-1210. 
If you have questions regarding CBT,contact 
Craig Koller via email or at 402-1427. 
PC BasicL Windows NT[2S & Email: 
The following classes will be held at MHC in 
the liS Training Room off the lobby of the 
main building. Please call317-4771 to 
register. Registration is required. 
PC Basics 
July 9 - 9-llam. 
July 23 - 9-11am. 
Windows NT/95 
July 9 - 1-3pm 
July 23 - 1-3pm 
Emaillntro. 
July 2 - 9-llam. 
July 16- 9-llam ( 
July 30- 9-llam. 
lldiaal ltd ~- .... lates 
Grand Round and 






II 12 CIR Tumor Board • 





5 7 am Surgical Grand 6 
Rouncla- CC-Aud 
8am Pedlalric Grand 
Rouncla- 17-Aud 
12 Noon Medical Grand 
Rouncla CC-Aud 
11 7am Ambulatory Clln IJ 12 Noon Pulmonary Tumor 
Guideline Ow· SON Board· JDMCC • CR1 NB 
7 am Surgical Grand 
Rouncla-CC-Aud· 
Bam Pediatric Grand 
Rouncla -17-Aud 
12 Noon Medical Grand 
Rounds cc-Aud 
19 7 am Surgical Grand 
Rounds· CC-Aud 
10 
Bam Pedlltric Grand 
Rouncla -17-Aud 
12 Noon Medical Grand 
Rounds cc-Aud 
16 7 am Suflllcal Grand 17 
Rounda·CC-Aud· 
Bam Pediatric Grand 
Rounds- 17-Aud 
12 Noon Medical Grand 
Rounds CC-Aud 
12 Noon UrolOgy Tumor 
Board • JDMCC • CR1 
AlB 
.-, 
THURSDAY FRIDAY SATURDAY 
12 Noon Combined I 7am OBGYN Grand 1 3 
Tumor Board - JDMCC - Rounds -17 Aud 
CR1NB 
12 Noon Breast Tumor 
Board • JDMCC. CR1 NB 
7 12 Noon Combined 8 7am OBGYN Grand 9 10 
Tumor Board • JDMCC • Rounds -17 Aud 
CR1NB 
12 Noon Pediatric Noon 
Conf·17Aud 
12 Noon Breast Tumor 
Board • JDMCc- CR1 NB 
M 12 Noon Combined IS 7am OBGYN Grand 16 17 
Tumor Board • JDMCC • Rounds -17 Aud 
CR1NB 
12 Noon Breast Tumor 
Board • JDMCC- CR1 AlB 
11 12 Noon Combined ll 7am OBGYN Grand D 14 
Tumor Board - JDMCC • Rounda-17 Aud 
CR1NB 
12 Noon Pediatric Noon 
Conf-17Aud 
12 Noon Breast Tumor 
Board • JDMCc- CR1 AlB 
18 12 Noon Combined 19 7am OBGYN Grand 30 ll 
Tumor Board - JDMCC • RoundiiiTumor Board -17 
CR1NB Aud 
12 Noon Breast Tumor 
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Permit No. 1922 
Medical Staff Progress Notes 
is published monthly to 
inform the Medical staff of 
Lehigh Valley Hospital and 
employees of important 
issues concerning the 
Medical staffs. 
Articles should be submitted 
to Janet M. Seifert, Physician 
Relations, Lehigh Valley 
Hospital, C8dar Crest & 1·78, 
P.O. Box 689, Allentown, PA 
18105-1556, by the 15th of 
each month. If you have any 
questions about the 
newsletter, please call Mrs. 
Seifert at (610) 402·8590. 
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